Archives: CannabisNewsWire

The Netherlands has had a unique model in which marijuana is neither legal nor illegal yet it is sold in coffee shops. However, the cultivation of cannabis is illegal in the country, so the cannabis products consumed in the licensed coffee shops are obtained from illegal sources. The government wants to end this situation by conducting experiments in the regulated production of cannabis.

To this end, ten cultivators have been selected and each one of them is expected to grow between six and ten different varieties of marijuana. The THC content of that marijuana will be prominently indicated on the product label.

Additionally, about six or ten local authorities will be selected to participate in this experiment. The cannabis grown by the selected cultivators will be exclusively sold in the local authorities that are selected for the program.

This planned experiment was revealed last year when consultations about the program started. The experiment will last for four years, so a final decision on the matter is likely to be made by the government or cabinet that is elected once the current one runs its course.

Already, opposition to this experiment has emerged from different quarters. For example, the umbrella body of the local authorities in the Netherlands (the VNG) says that the government will have a hard time getting local authorities that are willing to participate in the experiment.

This is because those selected areas will have to commit, and ensure that no cannabis from illegal sources is sold within their jurisdictions during the experiment.

Furthermore, the local authorities near borders are also expected to prevent cannabis from being sold to non-residents of Holland to prevent what the government is calling “drug tourism.”

In response to this criticism, the government stated that it would introduce the legally-grown cannabis in phases so that the participating local authorities and coffee shops don’t get rushed into the program.

The Council of State, which is the highest advisory body to the Dutch government, also criticized the cannabis experiment saying that its scope was too small. Just ten local authorities cannot be based upon to get representative information about the whole country, they said.

Nevertheless, the government is pressing on with its plan to announce the ten local authorities that have been selected to participate in this program by the end of this year.

Perhaps this approach of experimenting before passing laws legalizing or outlawing recreational cannabis needs to be adopted by other jurisdictions, such as the U.S. federal government. Such a controlled experiment can bring reliable results instead of passing laws based on preconceived ideas about the perceived effects of recreational cannabis.

Generation Alpha Inc. (OTCQB: GNAL) and Global Consortium Inc. (OTC: GCGX) look forward to the results of the Dutch experiment since those findings will provide valuable lessons that jurisdictions elsewhere can learn from.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Veterans Affairs Canada has revealed that marijuana use among veterans in the country has skyrocketed so much that $65 million was spent on weed for veterans last year. This rise in medical cannabis use not surprisingly coincides with a decline in the use of prescription opioids by the veterans.

Previously, injured veterans had to take a cocktail of medications for the different conditions they were suffering from. Major Mark Campbell (Rtd) is one such former soldier who lost both legs during a tour to Afghanistan.

The retired major calls cannabis “magic” because it was the only remedy that could give him some relief from the chronic pain he felt since his final tour of duty. He reveals that he has reduced the prescription opioids that he takes by half from the time that his doctor recommended that he tries medical marijuana.

He added that the fact that so many veterans are turning to medical cannabis shows that it works for them. They aren’t taking it just to be high 24/7, Major Campbell joked.

The statistics of cannabis use among Canadian veterans are staggering. For example, 10,000 veterans used medical marijuana in 2018 alone. This is much higher than the 1,700 who used weed in 2015.

That surge in number explains why the department of Veteran Affairs forked out $65 million last year to reimburse medical cannabis dispensaries that dispensed marijuana to vets. That expenditure on cannabis comes as the reimbursements for prescription painkillers are dropping.

For instance, reimbursements for the prescription opioid fentanyl have reduced by 85 percent in just five years while the reimbursements for oxycodone have registered a 75 percent reduction in the same five-year duration.

Veteran affairs experts say that they have witnessed firsthand the switch by veterans from prescription opioids to marijuana without the accompanying depression and other symptoms of withdrawal from the addictive opioids.

The experts, such as Zachary Walsh (a University of British Columbia psychology professor), say that cannabis also holds massive promise because of its ability to combat different health challenges simultaneously. For instance, the veterans who use cannabis say it helps them fight pain, anxiety and sleep disorders.

While the department of Veteran Affairs in Canada has been spending record-breaking amounts of money on medical marijuana for veterans, advocates say a lot still needs to be done. The advocates say the department has a huge backlog of disability benefits to process and they are woefully understaffed.

Addressing those concerns would go a long way in assuring the former members of the armed forces that their contribution to the nation is valued. Earth Science Tech Inc. (OTCQB: ETST) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) call on the federal government in Canada to fix the kinks in the Veterans Affairs department so that the injured former soldiers can access medical cannabis without any needless hassles.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Two separate cannabis bills have been passed by the Washington state Senate. One has to do with the use of medical cannabis in schools and another regards testing cannabis products before they get on the market.

The bill on medical cannabis in schools is intended to help students with chronic illnesses for which they are being treated using medical marijuana. The bill will allow those students to get their medical cannabis treatment while at school.

More specifically, the treatment will be administered by a parent, and not a school official or a nurse. This provision was intended to eliminate any liability issues that can arise from the administration of medical cannabis to students.

Secondly, the stipulation that only parents can administer medical cannabis to their children at school will also remove any issues that could have arisen regarding the licensing of the people administering medical cannabis to kids.

The senate bill also bans smoking medical cannabis on school premises. Students can therefore only receive medical cannabis edibles and other forms of marijuana. Cannabis products whose THC content is high are also banned from school premises. Most medical cannabis plants are carefully bred to have a high CBD content and very low, if any, THC.

The bill has a trigger clause that allows schools in Washington State to suspend accepting medical marijuana for students once the federal government threatens to cut off the funding of the schools over the medical marijuana program.

In a related development, the senate also passed a bill to modify the marijuana testing requirements of the state. This bill looks at various testing parameters, such as potency, mold, and pesticides.

The lawmakers observed that the existing law had gaps which allowed players in the cannabis industry to make some claims that are hard to verify on their product labels.

The bill wants to transfer oversight of cannabis testing labs from the Liquor and Cannabis Board to the Department of Ecology.

If the bill becomes law, the ecology department will be expected to table new testing guidelines in 2020 and 2021. These guidelines will stem the tide of facilities springing up and claiming to be cannabis testing labs.

The two bills had already got the nod from the state Assembly. The “yes” vote from the senate therefore means that the modified bills will be sent back to the House so that the lawmakers there can approve the changes made by the senators. Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) welcome the two bills because they will not only inspire confidence in cannabis products but also make it easy for students to receive their medical cannabis treatment while at school.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As New York State gets closer to legalizing recreational marijuana, the city council of New York has voted in favor of a bill that will ban employers from subjecting prospective employees to pre-employment cannabis tests.

If enacted into law, this bill will be a trailblazer because no other city or municipality in the U.S. has passed such a law explicitly stating that employers are no longer allowed to test job applicants for marijuana before considering them for employment.

The bill contains a clause that it will only be enacted a minimum of one year after the bill has been passed. This lag time is understood to mean that by the time the bill is enacted, the State of New York will have passed its own recreational cannabis legalization law.

Advocates for this bill in the City Council should have no fears because the Mayor of New York City has indicated on several occasions that he will sign the bill when the time comes.

This bill will apply to employees in both the private and public sector. However, some categories of workers would be exempted from the protections of this law. For example, truck drivers, pilots and police officers will still be tested for marijuana.

Similarly, employees who are suspected of smoking marijuana on the job will also not be exempted from this ban on employee testing.

The city council of New York also passed another bill that removes marijuana testing as a condition for parole or probation. This particular bill will be enforced as soon as the Mayor signs it into law.

Analysts say the bill on parole and probation could possibly have a more significant impact than the one on pre-employment cannabis testing. This is because the bill brings a major shift in the dispensing of justice in the City.

According to available statistics, more than half of the companies in New York City perform pre-employment marijuana testing. These tests are expensive, as each test costs approximately $31-$40.

However, the usefulness of such tests has been brought into question since cannabis metabolites can be detected in a sample of blood or urine months after the individual consumed marijuana. Additionally, a positive test result doesn’t give any indication of the frequency of cannabis consumption, or whether the person tested was impaired at the time the test was done.

As more states legalize either recreational or medical marijuana, the likelihood of getting a positive test result increases exponentially and it gets harder to decide what to do with those results since an individual can claim to have consumed cannabis months back when traveling through a state where it is legal.

ChineseInvesters.com (OTCQB: CIIX) and Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) applaud the framers of the bill since the law will prevent the needless waste of precious resources on drug tests for a substance that is legal in for medical use two-thirds of the country.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Whole smoking is the most common administration method for medical cannabis, not all patients are willing or able to use this method. For example, those who have respiratory challenges like asthma are unable to smoke cannabis because it may aggravate their condition. Terminally ill patients may also find it hard to smoke marijuana as part of their treatment. For such patients, two Israeli companies have teamed up to develop cannabis inhalers through which they can take their medication.

The two firms are Panaxia Pharmaceuticals and Rafa Pharmaceuticals. The two companies are working together to bring marijuana inhalers to the market so that patients have one more way to get their medication.

For now, the companies are targeting asthma and the pain suffered by cancer patients. The companies hope to avail an administration mode that will bring quick relief to cancer pain or respiratory distress resulting from asthma symptoms.

This administration mode may easily gain acceptance in the market for several reasons.

First, inhalers aren’t a new mode of administering medication to patients. Asthma sufferers carry them around, so it would not be hard for them to switch to the cannabis version.

Secondly, it is possible to determine what precise dose of cannabis a patient should receive when using inhalers since the patient can be told to inhale a given number of times at stipulated intervals in order to get the right dose of cannabis into the body. Medical practitioners can therefore easily see cannabis as medicine if its dosage can be controlled.

Additionally, inhalation can provide faster therapeutic outcomes when compared to other modes, such as consuming cannabis edibles. This is precisely why asthma sufferers often carry an inhaler so that they can use it and see results faster when an asthma attack occurs.

At the moment, the innovators are conducting clinical trials together with the Israeli Ministry of Health in order to ascertain whether the product is ready to hit the market, or some kinks remain which need to be resolved.

Meanwhile, the companies have decided to start a marketing drive for the inhalers while the clinical trial is ongoing.

The plan is to avail the inhalers on the Israel market later this year. Only patients with a doctor’s prescription will be able to access the product. It is not yet clear when the two companies will start exporting their invention to the rest of the world. Remember, the Israeli parliament passed a law towards the end of last year allowing companies that have been licensed by the state to export medical marijuana.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) congratulate the two Israeli companies for finding a solution to administering medical cannabis to patients who are unable to use the modes that are currently available on the market.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Legally, patients who qualify can access medical cannabis across the UK ever since an enabling law paved the way for this treatment to be available from November 1, 2018. However, the reality is another thing altogether as patients are made to jump endless hoops in order to access medical marijuana through the National Health Service (NHS).

The cumbersome bureaucratic system has compelled many desperate parents of kids who badly need medical marijuana to resort to smuggling the medicine from other countries.

Emma Appleby is one of those parents, and her story is heart-wrenching. She says her daughter, aged nine, suffers from severe epilepsy that causes the child to have more than 300 seizures every single day.

Appleby tried to follow the official channels in order to get her daughter on the medical cannabis that has been documented to help patients like her child. However, she got one flat “no” after another as she presented her case before various medical officials who had to approve her application before her daughter could get medical cannabis.

This rejection pushed Appleby to the edge and last week, she decided to take matters into her own hands. She travelled to the Netherlands and bought medical cannabis oil worth nearly $6,000. This was sufficient to treat her daughter for three months.

However, customs authorities seized the medicine as soon as she landed back home. She is angry that her daughter continues to suffer while the medical professionals and the NHS keep arguing about what sort of evidence is required for one to access medical marijuana.

Emma Appleby has vowed to fight until the seized medication is returned so that her child can be treated. Hers isn’t a farfetched dream, since there is a precedent on this issue.

Earlier this year, another parent, Charlotte Caldwell, also tried to smuggle medical cannabis into the UK but it was intercepted by customs. However, the medicine was quickly returned to her (in less than a week) after her sick son’s health deteriorated and he was admitted. Cannabis had been keeping the boy stable, so when he went without it as the authorities prevented his mother from treating him with the smuggled medicine then his health went downhill rapidly.

Such cases have led medical cannabis supporters in the British parliament to rise up in arms against the implementers of the medical cannabis law who have made it hard for the intended beneficiaries of that law to access badly needed treatment.

The program is so hard to navigate that only 12 patients have got licenses to receive medical cannabis since November 1 last year when the law came into effect. TransCanna Holdings Inc. (CSE: TCAN) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) sympathize with the parents who have been forced to try and circumnavigate the law in order to access medical cannabis. The authorities should do whatever is possible to make it easier for patients to get the treatment they need.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
The CBD market is seeing strong growth and a move towards the mainstream.

• The North American CBD market, worth more than $9 billion in 2017, is projected to be worth $47 billion by 2027.
• Growth is possible partly through mainstream acceptance, with pressure on a variety of institutions to accept medical CBD.
• Leaders are emerging within the CBD and cannabis markets, as leading voices gain recognition for their work.

Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile), which focuses on health and wellness products, is benefiting from this growth through the establishment of strong distribution deals. Focused on the organic market, Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) has significantly increased its output to meet demand. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has earned its CEO industry-wide recognition through strong growth and a powerful place as a market leader. HEXO Corp. (NYSE American: HEXO) (TSX: HEXO) is pushing CBD and cannabis toward the mainstream through connections with food and consumer product companies. Significant developments in science and agriculture, where Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) is making great steps forward in developing low-cost high-quality hemp, is also strengthening the plant.

To view the full editorial, visit http://cnw.fm/2irJo

To hear the CannabisNewsAudio version, visit http://cnw.fm/gbS9W

About Wildflower Brands

Wildflower Brands is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of the company’s brands work in synergy toward the goal of becoming a global wellness leader. For more information, visit the company’s website at www.WildflowerBrands.co.

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://cnw.fm/WLDFF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Recently, California passed a rule to allow the statewide delivery of cannabis. However, a legal battle between the state and 25 cities is brewing after the cities went to court to have that rule overturned.

When California legalized marijuana, local governments were given the right to decide whether cannabis businesses and sales would be permitted in their jurisdictions and the conditions under which such operations could be permitted.

Many local governments exercised their right and opted to ban recreational cannabis from their jurisdictions. The new rule allowing cannabis retailers to deliver cannabis to “any address” within the state has angered the local authorities and 25 of them have gone to court over the matter since the rule would, in effect, render their position to ban cannabis ineffective.

At the core of this lawsuit is a desire to determine whether it is the state regulators in charge, or the local authorities where marijuana is cultivated and sold.

Marijuana companies and consumers advocated for the passing of the rule allowing the delivery of cannabis in the state because there were large “marijuana deserts” created by the action of local authorities that banned marijuana in their jurisdictions.

Those “deserts” made it difficult for people, especially frail patients, in those areas to access cannabis and yet the products were legal in the state.

Prop 64, the law under which cannabis became legal in California, indicates that cannabis can be delivered anywhere in the state by employees of a licensed cannabis retail business.

The cities that have gone to court therefore seem to be interested in establishing whether that provision overrides their power to restrict cannabis businesses from operating within their jurisdictions.

The state insists that the delivery rule is merely reinforcing what is already in the law while the cities argue that cannabis businesses are trying to circumvent the ban imposed by local governments. The cities insist that the deliveries should only be to the areas where the local governments have consented to the operation of cannabis businesses in their areas.

Currently, California is the largest cannabis market within the U.S., but many residents have been finding it hard to buy marijuana because of the ban imposed by several local authorities. This case is therefore going to be a landmark one since the ruling may make a definitive determination of how the cannabis industry in the state will operate.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) and the entire marijuana industry are watching with bated breath to see how the court will rule on this latest source of friction between the state and the local governments.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Ever since the Compassionate Use Act was signed into law in 2007, no major changes had been made to it until last week when Gov. Michele Grisham appended her signature to Senate Bill 406. This bill, now a law, makes numerous changes to the medical cannabis law of New Mexico.

One major change that will take effect on June 14 has to do with medical cannabis in schools. Under the updated law, medical cannabis will be administered on school premises under specific circumstances. For this to happen, parents of kids on medical cannabis will present to the school a detailed treatment plan designed by a medical professional.

However, schools will still reserve the right to accept or outlaw medical marijuana if the school district thinks that their federal funding may be at risk.

The new changes to the law will also allow patients who have a license to grow their own medical marijuana to take their produce to a manufacturer for processing into edibles, concentrates or any other form desired by the patient. This will, of course, be at the expense of the patient.

Previously, only Non-Profit producers of medical marijuana could take it to manufacturers for processing.

Medical cannabis users from other states also have a reason to smile after the governor signed this bill. Out-of-state medical cannabis users will now be able to take part in the medical marijuana program of New Mexico. Previously, only residents could benefit from this program.

The validity period of medical cannabis cards issued by New Mexico has also been extended from one year to three years. This will save the time and expenses associated with renewing a card each year.

It has also been hard for patients to find a place outside their homes where they can consume medical cannabis. The new law intends to put an end to this since it contains provisions for the licensing of consumption areas. The only condition here is that those consumption areas have to be approved by the New Mexico Department of Health.

The law has provisions that cement the protections accorded to patients using medical cannabis. For example, a patient will not be fired from a job just because he or she uses medical cannabis. However, this protection doesn’t save you from being fired if you are under the influence while at your job. Similarly, a parent will not be denied visitation or custody rights on account of being a user of medical cannabis.

The entire cannabis industry, including Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), welcomes the updates which have been made to the cannabis law in New Mexico in order to bring the law in line with the evolving needs of the patients using medical marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: The CBD market is experiencing explosive growth as a result of growing mainstream acceptance and strong leadership.

• The North American CBD market, worth more than $9 billion in 2017, is projected to be worth $47 billion by 2027.
• Growth is possible partly through mainstream acceptance, with pressure on a variety of institutions to accept medical CBD.
• Leaders are emerging within the CBD and cannabis markets, as leading voices gain recognition for their work.

Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile), which focuses on health and wellness products, is benefiting from this growth through the establishment of strong distribution deals. Several companies are responding to the growth by expanding operations. Canadian-based Tilray Inc. (NASDAQ: TLRY) is adding production capacity in both Canada and Europe. Aphria (NYSE: APHA) (TSX: APHA) is increasing its indoor grow operations. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is focusing its development efforts on projects in the United States. And Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is using a significant outside investment to make…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Senate Bill 305, also called The Compassionate Access to Cannabis Act, has been tabled (this week) before a Senate Committee in California. The bill is intended to allow patients who are terminally ill to access medical marijuana while they are in hospital or other care facilities.

The bill is also referred to as “Ryan’s Law.” Ryan Bartell lost his life to pancreatic cancer at 42 years of age last year. After he was diagnosed with the disease, Ryan received high doses of prescription opiates in the Washington-based facility where he was admitted.

His family wanted to switch to cannabis, but they were dismayed to learn that the hospital where Ryan was admitted could not accept the use of cannabis on its premises. The Cannabis Nurses Network came to the rescue of the family and helped them to move the patient to another hospital where he could receive cannabis medications.

The cannabis medications produced astonishing results because Ryan remained alert and pain-free throughout his final days. In contrast, the opiates he had previously been taking kept him barely conscious and the pain didn’t go away.

Upon the death of Ryan, his father (Jim Bartell) hired a lawyer to help him to draft The Compassionate Access to Cannabis Act in memory of his son. Jim Bartell didn’t want other patients to be restricted to opiates that would deny them the chance to have some quality time with their families in their final days.

The federal Drug-Free Workplace Act compels all institutions that receive funding from the federal government to prevent the distribution and use of controlled substances, such as marijuana.

The bill before California’s senate committee wants to provide a way for medical facilities to put in place mechanisms by which patients receiving end-of-life care can, upon the recommendation of their doctor, access cannabis within the healthcare facility.

The bill will prevent a scenario in which hospitals scramble to find a way to provide medical marijuana. Instead, they will plan ahead so that once a patient or their doctor requests for medical cannabis, then the hospital would simply activate the system that they had established proactively.

If enacted, the bill will play a big role in bringing medical marijuana into the mainstream as far as the field of medicine is concerned. The stigma against medical marijuana can reduce drastically with this one measure.

VPR Brands, LP (OTC: VPRB) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) earnestly hope that Ryan’s Law is passed so that medical cannabis takes its rightful place among the treatments that patients can receive while in hospital.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

According to newly published research, the research-grade cannabis sourced from the only federally licensed cultivator (Mississippi University) is closer to hemp than the commercially available cannabis in the states where cannabis is legal.

The findings of this research bring into question the outcomes of the marijuana studies which have been conducted using the cannabis from the Mississippi farm. Do the results really help researchers to understand the real-world effects of cannabis?

Earlier research had demonstrated that the marijuana grown at the University of Mississippi using funds obtained from NIDA (National Institutes on Drug Abuse) had lower concentrations of THC and CBD when compared to the cannabis products that are commercially available.

However, the researchers from the University of Northern Colorado wanted to go a step further and compare the genetic composition of the federally-approved cannabis and what is on the market in states where cannabis is legal.

The researchers therefore obtained about 49 samples of hemp and cannabis taken from what is on the market and what NIDA avails to federally-approved research teams. The samples included sativa, indica and hybrid varieties of marijuana currently available on the market.

After analyzing these samples, the research team was surprised to find that the cannabis supplied by NIDA differed so much from what was on the market. The research-grade cannabis proved to be genetically closer to hemp rather than being similar to the cannabis consumers were accessing legally.

This outcome provides food for thought when one is thinking about using cannabis from NIDA to do research. If the research is focused on THC or CBD as standalone components, then the cannabis from Mississippi University can suffice.

However, if the study is intended to understand what effects cannabis has on the patients or recreational users, then the NIDA products aren’t appropriate since their use won’t mirror what people are consuming.

The findings of this Colorado study provide more momentum to the calls for expanding the federally-approved cultivators of research-grade cannabis in the U.S. While calls for interested parties to cultivate cannabis for research purposes were published, the Department of Justice has been very slow in processing the applications, so Mississippi University is still the sole federal source of cannabis for research purposes.

William Barr, the new U.S. Attorney General, has promised to look into the matter and take the necessary steps. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) hope that the research from the University of Northern Colorado triggers a sense of urgency in bringing more cultivators on board so that researchers can access cannabis of the right quality.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Lou Leon Guerrero, the Governor of Guam, has signed into law a bill that legalizes recreational cannabis in the U.S. territory. This signing comes after months of intense debate in this small Pacific island of 164,000 residents.

The law provides for the creation of a nine-member Cannabis Control Board which will draft the rules governing retail sales. The rules are scheduled to be drafted and debated in the course of this year. This board will also oversee the entire recreational cannabis program.

Under the newly passed legalization law, adults in Guam will be permitted to possess a maximum of an ounce of cannabis. Residents will also be allowed to grow six mature plants for their own recreational use.

Speaking at a press conference, Guerrero said that cannabis is the most used illicit drug, so the law was needed in order to regulate its use in order to protect minors and also benefit from its medicinal properties. She added that the new law will create a safer environment for the residents of the island territory.

It should be noted that Guam legalized medical marijuana back in 2014. However, the island has never licensed a testing lab, so the medical marijuana sector remains largely dormant. Home cultivation of recreational marijuana was also approved in 2018.

It is hoped that the legalization of recreational cannabis will add impetus to the efforts to operationalize the commercialization of cannabis both for medicinal and recreational purposes.

The cannabis law was passed without any stiff opposition. The only concern that was raised by some legislators regarded the federal status of cannabis. However, this matter was put to rest when supporters pointed out that the STATES Act was making its way through committees of Congress and this showed that the federal government would not interfere in any jurisdiction that had passed its own marijuana laws.

The STATES Act largely centers on making it possible for marijuana businesses to get access to banking and insurance services without any fear of federal repercussions upon the banks, credit unions and insurance companies that choose to do business with marijuana companies in the U.S. states and territories where marijuana is legal in some form.

The signing of the legalization bill makes Guam the second U.S. territory to legalize recreational marijuana. Northern Mariana Islands was the first territory to allow adult-use cannabis when it passed its cannabis law last year.

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and Sugarmade, Inc. (OTCQB: SGMD) welcome Guam into the fold of jurisdictions that have enacted laws to regulate the cannabis industry in order to tap the opportunities presented by this nascent sector.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The Judiciary Committee in Connecticut’s Assembly has also approved a bill that will pave the way for marijuana legalization. This is after the General Law Committee also approved a bill on cannabis legalization.

The move to legalize recreational cannabis in Connecticut is still in its early stages, and the legislators have opted to draft different bills covering different aspects of legalization before merging all those bills into one once they are passed by the relevant committees.

The bill before the Judiciary Committee was hotly contested and it passed with a slim majority (21 votes in favor and 19 against).

If the bill becomes law, adults who are 21 or older would be allowed to possess a maximum of 1.5 ounces of cannabis and a maximum of 5 grams of cannabis concentrates. The bill outlaws the home cultivation of cannabis.

During the meeting of the Judiciary Committee, some members expressed concerns about the possible effects of cannabis legalization on impaired driving and youth consumption. However, many of these individuals acknowledged that voting against the bill would be a futile undertaking since cannabis legalization was inevitable.

The bill eventually passed, and it is now headed to the Finance Committee. Thereafter, the different bills will be combined into one prior to being tabled before the entire legislative assembly for consideration.

Cannabis advocates generally support the bill, although they suggest that it should be improved in several aspects.

One area of improvement suggested by the Marijuana Policy Project has to do with the expungement provisions. The advocates suggest that all prior cannabis convictions should be expunged. They also want the bill to include a provision that allows residents to grow their own recreational marijuana.

Other advocates also want the law to be clear about the way in which the different communities that suffered the brunt of the so-called war on drugs can benefit from the opportunities created in the legal cannabis industry.

As things stand, both sides on this debate may have to make concessions if the bill is to have a chance of becoming a law soon. Otherwise, a lack of consensus and compromise may create a situation similar to what has played out in New York State where adult-use cannabis could not be included in the state budget due to disagreements regarding the way in which the legalization policy would be implemented.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) and SinglePoint Inc. (OTCQB: SING) hope that the path to cannabis legalization gets smoother as the different bills leave the different House Committees in Connecticut.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: The CBD market is seeing strong growth and a move towards the mainstream.

• The North American CBD market, worth more than $9 billion in 2017, is projected to be worth $47 billion by 2027.
• Growth is possible partly through mainstream acceptance, with pressure on a variety of institutions to accept medical CBD.
• Leaders are emerging within the CBD and cannabis markets, as leading voices gain recognition for their work.

Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile), which focuses on health and wellness products, is benefiting from this growth through the establishment of strong distribution deals. Focused on the organic market, Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) has significantly increased its output to meet demand. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has earned its CEO industry-wide recognition through strong growth and a powerful place as a market leader. HEXO Corp. (NYSE American: HEXO) (TSX: HEXO) is pushing CBD and cannabis toward the mainstream through connections with food and consumer product companies. Significant developments in science and agriculture, where Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) is making great steps forward in developing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

New cannabis laws that were passed in Israel on April 1 decriminalize recreational cannabis. This means that people found with small amounts of cannabis will be fined instead of facing criminal charges if those individuals don’t have a license to use medical cannabis.

The day when adult-use marijuana was decriminalized was also the day when the fourth edition of the annual CannaTech conference was held in Tel Aviv. Ehud Barak, a former Israel premier, spoke eloquently at the CannaTech conference about the immense benefits of medical cannabis. He went as far as saying that the Israeli motto may be updated to “the land of milk, honey and cannabis.”

Why would Ehud Barak deliver a keynote address at a cannabis conference? It so happens that the former premier is the chairman of an Israeli medical marijuana company called Canndoc/Intercure.

Barak joins a growing list of politicians who previously opposed cannabis but are now ardent advocates. He joins the likes of former speaker of Congress, John Boehner. Vicente Fox, the former president of Mexico, also changed from being a kingpin in the fight against marijuana to calling for an overhaul of prohibitionist marijuana laws.

Ehud Barak pointed out during his keynote address that the future of marijuana belonged to the bigger and more assertive players who would “swiftly enter the cannabis market.”

He was referring to the decision of the Israeli parliament that passed a law in December last year paving way for Israeli companies to export medical marijuana. This law positioned Israel to be one of the biggest players in the international marijuana industry.

Barak also talked about Israeli cannabis companies like Tikun Olam (a Hebrew expression meaning “repair the world”) that already had a major stake in the cannabis market. This company alone commands an estimated 40 percent share of the global medical cannabis industry.

His statements should not be taken lightly, because major milestones, such as the discovery of the endocannabinoid system in humans, can be traced to Israeli doctors or researchers.

Meanwhile, the Ministry of Health in Israel has revealed that more than 550 farms in the country have submitted their applications for licenses to grow medical cannabis. There is no guessing which market these cultivators are eyeing, since the local market cannot utilize all the cannabis grown by these farms.

Israel has a short list of qualifying conditions for which patients can get a prescription for medical marijuana. These include epilepsy, Parkinson’s, cancer and many other terminal illnesses. Most of the medical cannabis grown in Israel is therefore likely to be headed out of the country.

MustGrow Biologics Corp. and Net Element, Inc. (NASDAQ: NETE) congratulate Israel upon taking the important step of decriminalizing recreational cannabis. The next step should now be full legalization.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Every year, a Hash Bash festival is held in Ann Arbor as a day of having fun and entertainment. This year, law students at Michigan Law School worked with the organizers of the Hash Bash festival to host an event at the law school to discuss marijuana legalization politics.

This event was held yesterday (Sunday, April 7) while the Hash Bash took place on Saturday. The organizers of the event at Michigan Law School wanted to educate members of the public about issues related to marijuana. Several panelists made presentations on various issues.

Ari Goldstein, a law student who was one of the organizers, remarked that marijuana legalization brings entrepreneurial opportunities that haven’t been seen since the Great Depression, so every effort must be taken to prepare people to seize those opportunities.

Kevin Boehnke, who is a research fellow at Michigan University’s Department of Anesthesiology, revealed during his presentation that several patient studies point to the fact that more patients are opting for medical marijuana to manage pain instead of using prescription opioids.

The shift is due to the better symptom relief experienced by patients, and the concerns about the documented side effects of prescription opioids.

Another panelist, Gus Rosania (a professor of pharmacological sciences) handled the topic of natural vs. synthetic cannabis ingredients. Rosania dispelled the misconception that synthetic cannabis is different from natural cannabis.

He revealed that at the basic level, synthetic marijuana is chemically identical to natural marijuana, so it is hard to tell the two apart. He added that it was only because different ingredients could be isolated and made in a lab that it was possible to identify the different cannabinoids in marijuana.

Andrew Brisbo, the head of Michigan’s Bureau of Marijuana Regulation, was also in attendance to talk about the ramifications of the legalization of recreational cannabis in the state. He revealed that he had a huge task on his desk to put together a program for recreational cannabis implementation in just a year from the time the law was passed.

Brisbo intimated that one way that he was using to get everything done correctly is by engaging different stakeholders in order to tap their perspectives when putting together an implementation plan.

Many people in the audience expressed their frustration about how hard it was for them to get a medical cannabis prescription from their doctors. Brisbo expressed sympathy for their plight and revealed that it wasn’t easy to change attitudes about cannabis after such a long time of prohibition. He added that efforts were underway to give physicians more information about medical cannabis so that they can gradually warm up to prescribing it to their patients who qualify for such treatment.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America, Inc. (OTCQB: MCOA) welcome such engagements between regulators, patients, professors and other stakeholders since such interactions can result in better cannabis industry policies.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Barely a month ago, Gov. DeSantis signed a bill to allow patients to smoke medical marijuana after protracted legal battles which ended when court ruled that banning smokable marijuana was unconstitutional. Now a bill to regulate the strength of the smokable medical marijuana has been passed by a House committee amidst protests by medical cannabis advocates.

On Wednesday (April 3), the Health and Human Services Committee decided that the THC content of the marijuana flower that patients wish to smoke should not exceed 10 percent.

Medical cannabis advocates protested, saying that such a cap didn’t even reflect the strength of the cannabis already on the market. The advocates say that higher THC levels are necessary for triggering the therapeutic effects that patients have been enjoying when they use medical marijuana.

The advocates also say that the cap will make medical cannabis more expensive since patients may need to buy more in order to get the effects that they were getting when using more potent cannabis.

Those against this cap also say that the state has just handed a lifeline to the black market since patients are likely to shun legal weed in favor of more potent marijuana on the black market.

In general, the Republicans on the committee were in favor of the cap while the Democrats didn’t want the limit to be passed.

Ray Rodrigues, the chair of the committee, argued that there was research showing that marijuana with a THC concentration that is higher than 10 percent can cause psychosis in some patients while marijuana with less than 10 percent THC content was therapeutic.

He rejected calls for Florida to first study the effects of higher levels of THC on patients before imposing such a cap. The chairman responded that while medical cannabis was relatively new in Florida, it had been around for decades in other states, and the data there shows that high THC levels can be problematic.

Out of the 33 states and the District of Columbia where medical cannabis is legal, 14 have THC limits on medical marijuana. Rodrigues said that most of those 14 states impose a limit that is much lower than what is being proposed in Florida.

Currently, more than 200,000 people have medical cannabis identification cards in Florida. It is not clear how the THC limit will affect their buying habits, and whether more people will enroll for the program.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Green Hygienics Holdings Inc. (OTCQB: GRYN) hope that more robust debate will be conducted when this proposed bill is tabled before the entire House prior to its passing so that the limit set doesn’t push patients to the black market.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The state assembly in Georgia has passed a bill that will allow medical marijuana to be grown and processed within the state. With the Governor ready to sign the bill, there seems to be no hurdle to medical marijuana becoming a reality.

HB 324 was drafted in order to address the gaps that were created by a law passed in 2015 legalizing the use of low-THC cannabis oil for the treatment of a given set of medical conditions.

However, that law didn’t create any provision for the cultivation, sale or possession of cannabis oil within Georgia.

The bill that has just been passed addresses all those loopholes. It creates avenues through which cannabis can be grown for the extraction of low-THC marijuana oil. The bill also allows the creation of a commission to oversee the medical cannabis industry, as well as license different entities like universities which wish to take part in the manufacture of cannabis oil.

HB 324 doesn’t legalize recreational cannabis in the state, and it doesn’t have any provisions that allow the smoking of cannabis within the state.

It has been reported that Governor Kemp did a lot to help the assembly and the senate to reach a consensus on how the illegal distribution of marijuana will be prevented in the state. This compromise paved the way for the passing of HB 324.

Kemp said, “I have met several kids struggling with debilitating diseases, as well as parents who are losing hope that their kids can be helped. Medical cannabis offers hope to such parents.”

Kemp added that legalizing medical marijuana was the right thing to do, and that was why he invested so much in seeing to it that both legislative houses approved the bill.

If the bill is finally enacted into law, Georgia will join the long list of 33 states that have legalized medical marijuana.

Advocates may not be happy that the state is only allowing the use of cannabis oil, but it is at least a good start. Reforms can be introduced later when the program is being implemented and the patients, as well as the regulators, realize that other forms of cannabis, such as creams and edibles, may be needed.

All in all, the entire cannabis industry, especially Global Payout, Inc. (OTC: GOHE) and Golden Developing Solutions, Inc. (OTC: DVLP) congratulate the lawmakers in Georgia for making it possible for patients to have one more treatment option as those patients battle with the conditions afflicting them.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
A surge in hemp production means big business for hydroponic suppliers.

• Hemp production set to massively increase in the United States this year.
• Increased production driving high demand for hydroponic supplies.
• Hydroponics companies are responding with expansion and acquisitions.

Sugarmade Inc. (OTC: SGMD) (SGMD Profile) has strategically acquired several companies to meet demand and expand its foothold. Canadian-based Tilray Inc. (NASDAQ: TLRY) has expanded production in both Canada and Europe while Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is developing projects in the United States, and Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has received massive outside investment to fuel its growth. Companies such as Aphria (NYSE: APHA) (TSX: APHA) are enlarging their indoor grow operations as they too rush to meet demand.

To hear the CannabisNewsAudio version, visit http://cnw.fm/YPs6l

To view the full editorial, visit http://cnw.fm/6iajJ

About Sugarmade, Inc.

Sugarmade, Inc. is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include BizRight, LLC, Athena United, CarryOutSupplies.com, and BudLife Cannabis Storage Solutions. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at www.cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
The U.S. Farm Bill that recently passed into law is a game-changer for the CBD space. While it is unknown when nationwide cannabis legalization may occur, incredible opportunities exist right now for CBD-focused companies that can deliver products to the marketplace.

• Demand is growing for organic CBD products in markets where such products are legal.
• Youngevity has made a series of strategic acquisitions to help establish the company’s position
• Companies ready to deliver CBD products to market at scale are in ideal position to capitalize on growing demand.

Passage of the latest U.S. Farm Bill marked a watershed moment for CBD producers in the United States. Not only does the new body of law allow these producers to commercialize existing CBD products, the door is now open for a new generation of research into what CBD can do for consumers. Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) is a leading producer of consumer-focused CBD products that is expanding its reach into other areas of the CBD supply chain. It joins companies such as CV Sciences Inc. (OTCQB: CVSI), Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF), GW Pharmaceuticals plc (NASDAQ: GWPH) (OTC: GWPRF), and Curaleaf Holdings Inc. (OTCQX: CURLF) (CSE: CURA), which are all working to commercialize CBD products in both the consumer and pharmaceutical sectors.

To hear the CannabisNewsAudio version, visit http://cnw.fm/3p5Wc

To view the full editorial, visit http://cnw.fm/78f0W

About Youngevity International Inc.

Youngevity International Inc., an emerging conglomerate operating in three distinct business segments including a vertically integrated coffee enterprise, a vertically integrated hemp-based product development enterprise including end-to-end processing, and a direct-selling enterprise that consists of an expanding portfolio of consumer brands developed with its in-house product development team and distributed by traditional and nontraditional channels, including a multi-country, direct-selling network. For more information, visit the company’s website at www.YGYI.com

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The Irish government has revealed that it has finally identified and issued an import license to a Danish medical cannabis firm. The license was reportedly issued back in January.

Slightly more than two years ago, Simon Harris, the Irish Health Minister, announced that Ireland would create a medical cannabis program for its patients who couldn’t be helped by the existing conventional treatments for their health conditions.

However, little seemed to happen from the time that announcement was made. The revelation that a medical marijuana supplier had been found and licensed is therefore welcome news to the medical cannabis advocates in the country.

The government explained that it delayed to secure a supplier because it wanted to be convinced about the ability of that selected firm to deliver medical cannabis of verifiable quality, but many firms wouldn’t be able to export medical cannabis to Ireland.

The Ministry of Health has also confirmed that its staff is working tirelessly to finalize drafting the enabling legislation that will operationalize the medical cannabis program. The draft law may be ready by mid-April.

The medical cannabis that will be imported is intended to treat patients with nausea and vomiting due to chemotherapy, patients suffering from multiple sclerosis as well as patients suffering from severe epilepsy.

These qualifying conditions are part of the recommendations that were made by HPRA (Health Products Regulatory Authority) when it looked into the viability of medical cannabis and wrote a report in favor of setting up the medical cannabis program.

As the country waits for the operationalization of the medical cannabis program, doctors are allowed to prescribe medical marijuana to the patients that they are convinced can benefit from these products.

These patients are then required to apply to the Minister of Health for a license that can allow them to travel abroad to buy medical cannabis and bring it into Ireland.

As you may imagine, this process is a tedious and expensive one. It is therefore no surprise that in more than a year, the ministry has only granted licenses to just a dozen people. Most of these individuals obtained their medical cannabis from medical cannabis pharmacies in the Netherlands.

The enactment of the Cannabis for Medicinal Use Regulation bill will bring a sigh of relief to the patients who desperately need medical cannabis but cannot afford to travel abroad frequently in order to obtain it. Earth Science Tech, Inc. (OTCQB: ETST) and FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) hope that the authorities in Ireland speed up all the necessary processes so that patients can access medical cannabis locally.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As the cannabis market matures in different jurisdictions within the U.S., producers are fine-tuning their products in order to make those products more appealing to different segments of the market. One of the ways to target a niche market is by having your product certified as organic.

However, such food classifications are controlled at the federal level in the U.S. and since marijuana is still illegal at the federal level, no marijuana product can be federally certified as organic.

So, what have marijuana producers decided to do?

Several certification bodies have taken root in different states. The most respected certification for cannabis is the “Clean Green Certified”. However, many of the other certifications don’t carry as much weight as the “certified organic” badge on a product’s packaging material.

In order to take cannabis products to the niche market, a producer in California has decided to get a certification that has a religious twist to it.

Mission Kosher Cannabis Inc. is a cannabis company owned by Mitch Davis. Davis decided to have his products certified by a third-party (kosher) in order to be different from the other cannabis producers who were getting their certification from within the cannabis industry.

With the help of Rabbi Levy Zirkind, Mitch Davis is creating kosher certification standards for cannabis after he got his own products Kosher certified.

For those who may not know, kosher certification is very different from organic certification. A product can be kosher certified even if that product isn’t organic.

Kosher certification is all about product cleanliness. The product should not have any bugs in it. The product should also be free from pest infestations. Cleanliness is of the essence. There is a rigorous inspection process that has to be done to check all the boxes on these items before one gets the coveted kosher certification.

Additionally, one’s production system has to undergo random inspections in order for the product to retain its certification.

Mitch Davis says he loves the kosher certification because it has helped him to gel his workforce into a unit. All of the employees know that everything must be clean at all times because you can never know when the kosher inspectors will pass by.

When the inspectors visit, they take a close look at the facilities, such as where the cannabis plants are grown, how they are grown and where they are processed. They check the plants and harvested cannabis bud for pests and they also want to confirm that the employees in the grow rooms are wearing the recommended apparel.

With a kosher certification, who can really miss the federal organic certification?

Generation Alpha, Inc. (OTCQB: GNAL) and Global Consortium, Inc. (OTC: GCGX) congratulate Mitch Davis upon thinking outside the box and coming up with a novel way to show clients that cannabis producers are willing to do everything possible to bring them products of the highest quality possible.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As legislators on Rhode Island are thinking about legalizing recreational cannabis, the data on medical cannabis sales shows that the volume of products sold is setting state records year by year.

Currently, the state has three licensed dispensaries selling medical cannabis products. These dispensaries are on course to sell medical cannabis products worth about $56 million during the 2019 fiscal year.

If that target is hit, it will mark a 46.6 percent increase from the total sales of the previous fiscal year (2018). Medical cannabis sales for 2018 were also approximately 33.3 percent higher than what was registered in 2017.

As you can see, the medical cannabis industry on Rhode Island seems to be growing at an unstoppable pace year by year.

Rhode Island has a fairly short list of medical cannabis qualifying conditions when compared to other states where similar programs exist. However, the definition of those conditions is broad and it allows anyone with the symptoms of the listed conditions to access medical cannabis.

The state has about 18, 200 patients who are active on the medical marijuana program. Active patients are those who regularly buy medical cannabis products from the licensed dispensaries.

The uptick in medical cannabis sales has given the state a much-needed boost to its revenue. For example, the state earned $2.75 million as taxes on various aspects of the medical cannabis industry.

In this fiscal year, the state expects to earn almost double what it earned during the last fiscal year. Projections indicate that the state will collect about $5.4 million in taxes from the medical cannabis industry.

In the meantime, there are proposals to legalize recreational cannabis and also expand the medical cannabis sector. One of the proposals seeks to increase the number of dispensaries to nine.

Previous attempts to increase the number of dispensaries have been successfully resisted by the existing three dispensaries who argued that bringing in more players would hurt their businesses and result in possible closures.

However, those who want more dispensaries to be licensed argue that patients aren’t having sufficient access to dispensaries since the existing ones aren’t equally spread out across the state. Additionally, the lack of robust competition in the medical cannabis sector has denied patients competitive prices and access to a broader variety of products.

Advocates are therefore asking regulators to give priority to dispensaries that wish to operate in areas where none currently exists, and new operators should be brought on board before the existing ones are allowed to open additional compassion centers (medical cannabis dispensaries).

These reforms seem reasonable enough, and the regulators would be well advised to act upon the suggestions made. Cannabis Strategic Ventures, Inc. (OTC: NUGS) and Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) hope that the state will act on the proposed reforms so that patients can have easier access a wider variety of products at competitive prices.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

When the $17 billion state budget was adopted without marijuana policy reflected in it, cannabis advocates were crestfallen because they realized that their dream of seeing marijuana legal for adult-use had just taken a major hit. However, Governor Andrew Cuomo has vowed that he will do everything possible to pass the law by June when the legislative session ends.

The Governor said that the problem wasn’t the lack of political will to pass the law. Rather, there were differing opinions regarding the way in which legalization would be implemented in the state.

Because of those differing views on implementation, it wasn’t possible to reach an agreement on the matter while getting a budget ready for adoption. Now that the budget is out of the way, Cuomo feels that his full attention can now be devoted to hammering out the details of how recreational cannabis will be taxed, regulated and social justice attained.

Many lawmakers aren’t as optimistic as the Governor regarding the chances of the bill now that it isn’t included in the budget. For example, State Sen. Diane Savino points to what happened in neighboring New Jersey where marijuana advocates thought they had a done deal but voting on the legalization bill was cancelled due to fears that not enough “yes” votes had been secured in the State Senate.

That sobering example from New Jersey shows how tough things could get in New York State now that marijuana policy wasn’t included in the state budget.

It should also be remembered that out of the 10 states and Washington, D.C. that have legalized recreational pot, only one did so by legislative means. All the other states relied on ballot measures or referenda to legalize recreational cannabis.

This statistic shows that the general populace is always ahead of the lawmakers who have the responsibility to make decisions on behalf of the people that they represent.

It is therefore going to be a great deal harder for a majority of the lawmakers in New York State to pass a standalone marijuana legalization bill.

Already, there was intense opposition even while there was a chance that marijuana legalization would be included in the state budget. For example, the leaders in two of the New York suburbs with the largest population have already indicated that the sale of recreational cannabis will not be allowed in those jurisdictions.

TransCanna Holdings Inc. (CSE: TCAN) and Vivo Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) hope that the lawmakers can put aside their political differences and put the interests of New Yorkers first when discussing the way forward on marijuana legalization.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: The U.S. Farm Bill that recently passed into law is a game-changer for the CBD space. While it is unknown when nationwide cannabis legalization may occur, incredible opportunities exist right now for CBD-focused companies that can deliver products to the marketplace.

• Demand is growing for organic CBD products in markets where such products are legal.
• Youngevity has made a series of strategic acquisitions to help establish the company’s position
• Companies ready to deliver CBD products to market at scale are in ideal position to capitalize on growing demand.

Passage of the latest U.S. Farm Bill marked a watershed moment for CBD producers in the United States. Not only does the new body of law allow these producers to commercialize existing CBD products, the door is now open for a new generation of research into what CBD can do for consumers. Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) is a leading producer of consumer-focused CBD products that is expanding its reach into other areas of the CBD supply chain. It joins companies such as CV Sciences Inc. (OTCQB: CVSI), Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF), GW Pharmaceuticals plc (NASDAQ: GWPH) (OTC: GWPRF), and Curaleaf Holdings Inc. (OTCQX: CURLF) (CSE: CURA), which are all working to commercialize CBD products in both…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

CannabisNewsWire Editorial Coverage: A surge in hemp production means big business for hydroponic suppliers.

• Hemp production set to massively increase in the United States this year.
• Increased production driving high demand for hydroponic supplies.
• Hydroponics companies are responding with expansion and acquisitions.

Sugarmade Inc. (OTC: SGMD) (SGMD Profile) has strategically acquired several companies to meet demand and expand its foothold. Canadian-based Tilray Inc. (NASDAQ: TLRY) has expanded production in both Canada and Europe while Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is developing projects in the United States, and Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has received massive outside investment to fuel its growth. Companies such as Aphria (NYSE: APHA) (TSX: APHA) are enlarging their indoor grow operations as…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

When recreational marijuana was legalized across Canada on October 17, 2018, Ontario decided to start by only availing cannabis through a website run by the provincial government. Brick-and-mortar stores were slated to open in April this year, and yesterday (April 1) was the first day of storefront sales.

The provincial government decided to use an unconventional way to select which applicants would be granted the first 25 recreational cannabis retail licenses early this year. It used a lottery to select the lucky 25 businesses to be first to open retail stores. Originally, the plan was to license as many retailers as needed.

However, the persistent countrywide supply shortages compelled the government to change its plan and issue only 25 licenses in preparation for the April 1 deadline for the commencement of brick-and-mortar retail sales of pot.

The entities that participated in the lottery were fully aware that the licenses they received were subject to strict conditions, such as being ready to open by April 1.

Those that didn’t open their stores on that first day would face a fine of $12,500, and the fines would escalate the longer the business didn’t open. This penalty would be deducted from the $50,000 letter of credit that the applicants submitted as part of the preconditions for participating in the lottery.

If a licensee is unable to start operations by this month’s end, that business risks losing the entire $50,000 covered by that letter of credit.

That threat is likely to hit several businesses, since only 10 were able to fulfill all the licensing conditions in order to open on April 1. The race is therefore on for the remaining 15 businesses to reduce the fines that they will suffer as a result of their inability to open on the first day of storefront sales.

Meanwhile, Ontario residents have been waiting eagerly for the retail stores to open. This can be evidenced by the hundreds who started queuing as early as 4 a.m. in order to be among the first to buy pot in a “real store”.

Why would one sacrifice their sleep and yet recreational marijuana is already available online in the province? Each person has his or her own reasons, but a few seem to cut across.

For example, many are excited and want to be witnesses to the making of history in the province. To such people, the experience of walking into a store and paying for cannabis is something that truly marks the end of prohibition, and they wanted to experience it firsthand.

Many other people say that they are lining up at the stores because it gives them a better shopping experience. For instance, one can smell a product before deciding whether to buy it, something that isn’t possible when you order online. Stores also give you a chance to get up close and personal with the different products before you take your pick of what is available. This is worth lining for, they say.

ChineseInvestors.com (OTCQB: CIIX) and Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) hope that the residents of Ontario can enjoy buying from these retail outlets without being hindered by supply shortages.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

On Thursday last week (March 28), Judge Stephen Borrello of the Michigan Court of Claims issued a temporary order stopping the state from implementing its decision to close down any medical marijuana dispensary that hadn’t received its license by March 31.

The restraining order gives the businesses in question another 14 days within which to get their operations legalized in accordance with the licensing requirements of the state.

For long, players in the Michigan medical marijuana industry have been complaining that the state takes an inexplicably long time to process and issue a license to an applicant. This slow bureaucratic pace has affected growers, manufacturers and dispensing outlets.

For example, in early February alone, about 150 dispensaries were still awaiting the outcome of their applications for licenses. Similarly, 130 prospective medical cannabis cultivators were also awaiting the fate of their applications for grow licenses.

Because of those complaints, the state decided to allow medical cannabis businesses to open while their applications were still being processed.

However, the state eventually set deadlines for all unlicensed dispensaries to close, but these deadlines have either been unilaterally postponed by the regulators or courts have intervened and forced the state’s hand.

This recent extension is an example of the judiciary stepping in and compelling the state to refrain from implementing its decision to close medical marijuana businesses without licenses.

In response to the restraining order issued by the Court of Claims, the state published a statement in which it revealed that it will hit the brakes on its decision to close unlicensed medical cannabis businesses until court issues further orders or the pending litigation is disposed of by the courts of law.

In a bid to put an end to the endless delays in the licensing process, the Governor of Michigan, Gretchen Whitmer, has established a new agency to superintend over the marijuana industry.

The persistent problems over licensing issues have also come to a head as the state is working to start recreational cannabis sales after voters approved adult-use marijuana during the midterm elections towards the end of last year.

Cannabis advocates worry that if the problems in the medical cannabis sector aren’t fixed in time, then those problems will get worse once recreational cannabis is added to the menu. Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Youngevity International, Inc. (NASDAQ: YGYI) call on the regulators to study what other states have done to streamline the licensing process. Creating new agencies to oversee the industry may not fix the problem if a proper diagnosis of the issues isn’t done.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Recreational marijuana has been legal in Colorado since 2012, but the people who buy legal pot have been having a hard time finding where they can consume their purchase. This is now set to change if a bill that has been approved by a House Committee eventually gets the nod from the entire State Assembly and Senate.

Under current law, recreational cannabis can only be consumed in private residences and private establishments. The ban on public and open consumption of cannabis remains in place even if the law legalizing recreational cannabis intended to regard recreational cannabis in the same way that alcohol is treated by the law.

In the past, all efforts to create a system by which the social consumption of marijuana could be licensed have failed. However, the sponsors of HB 1230 feel that the time may now be right for an enabling to law to be enacted so that businesses can get licenses for the social consumption of marijuana on their premises.

Representative Jonathan Singer, the sponsor of the bill, says that his intention is to fix two major issues in the law.

First, his bill will provide more clarity about the meaning of “open and public” so that cannabis businesses and consumers can know the limits of where cannabis consumption is allowed or not. Currently, marijuana seems to be in no man’s land on this issue, he added.

By defining what “open and public” means, it will be possible to license premises where tourists and residents can consume recreational marijuana. This is especially important because many people who live in rented premises cannot consume recreational cannabis at home because the landlords don’t permit its consumption on the premises.

HB 1230 seeks to create two kinds of licenses that businesses can apply for in order have cannabis users consume their stuff in the premises.

The first kind of license will enable consumption lounges and other public places to have a limited amount of cannabis that people can buy and consume while in the premises.

The second type of license wouldn’t allow on-site cannabis sales, but people can come in with their own cannabis and consume it from those premises.

However, any business that is licensed to sell or facilitate the consumption of alcohol wouldn’t be eligible for any of the cannabis social consumption licenses. Under the proposed law, local authorities would also have the right to decide whether to permit or ban cannabis consumption lounges and other such facilities within their jurisdictions.

Now that the bill has passed the first hurdle in the Business Affairs and Labor Committee of the House, it now heads to the House Finance Committee. The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) and Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) hope that this bill is enacted into law so that the dilemma of where people can consume legal weed in Colorado can be solved sooner rather than later.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

On Thursday last week (March 28), the House Financial Services Committee voted to pass a bill that will make it easier for cannabis businesses to access banking services. The bill will now be scheduled for consideration by the entire House after it passed at the committee level when 45 legislators voted in favor while 15 voted against the bill.

Marijuana advocates see this committee action as a sign that the Democrats who dominate the House are finally making good on their support for cannabis law reform.

The bill seeks to make it possible for marijuana businesses to get access to banking services without any fear of federal action against them. Some of these businesses are working with some banks, but the majority of the financial services providers are reluctant to accept cannabis businesses as clients for fear of violating federal money laundering or illicit drug laws.

The SAFE Act was passed after being debated for several days in which a number of amendments were considered and either passed or rejected when a vote on them was called.

For example, one amendment sought to compel the federal government to conduct research on inclusion and diversity in the cannabis industry so that the damage caused by the war on drugs on minorities can be corrected.

Another amendment that was included in the bill added insurance companies to the list of entities that would be protected by the SAFE Act. It should be remembered that cannabis businesses have also been finding it hard to access insurance services that are vital for any business. If the bill becomes law, then marijuana companies will be able to access insurance services in the same way that other legitimate businesses can.

Another amendment added will compel the Government Accountability Office to study the reports banks are required to file about the marijuana businesses they have as clients. This examination is intended to find out how effective those reports are in helping the authorities to unearth illegal activity.

Those reporting requirements have previously been mentioned as one of the major reasons why it is very expensive for cannabis businesses to access banking services even when some banks are willing to accept these businesses as clients.

One proposed amendment tabled by a Republican legislator wanted to delay the implementation of the SAFE Act until the federal government rescheduled marijuana. Sensing that the amendment wouldn’t pass, the mover withdrew it before it could be voted on.

Many of the amendments that were rejected were mainly proposed by Republicans who wanted to cleverly water down the impact of the proposed law or even render it unenforceable. But the Democrats used their majority on the committee to sidestep all those traps.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) are glad that Congress is finally acting to enact laws that bring U.S. cannabis businesses into the fold of all other legitimate businesses across the country.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The Impaired Driving Safety Commission, a body that was set up by Michigan’s Governor, has recommended that the state should not set any threshold for the THC content in someone’s blood before that person is regarded as being impaired while driving.

This six-member panel was mandated to find a scientifically-backed limit for THC in blood and suggest what provisions should be put in the law to define when a driver is impaired by cannabis.

The members of the commission include a toxicologist, a law enforcement officer, a medical cannabis patient, doctors and cannabis use and traffic experts.

This panel wrote in its report that there was no scientific information upon which they could base a decision on how much THC in someone’s blood renders that person impaired while driving.

Additionally, the commission stated that there wasn’t any correlation between the amount of THC present in a driver’s blood and driving impairment.

The members also observed that according to the research they reviewed, the THC content in someone’s blood drops rapidly shortly after the person consumes cannabis. Conversely, impairment increases slowly and reaches its peak long after THC levels have dropped in that individual’s blood.

The issue of impairment is also affected by someone’s history of cannabis consumption. For example, a non-regular user of cannabis may become impaired after taking a small amount of marijuana.

However, a more regular user may require a larger dose of the substance in order to be impaired to the same degree as the individual who is an irregular user and consumed a little cannabis. Consequently, the commission recommended that the THC level in someone’s blood was a poor determinant of whether that person was driving while impaired.

The panel then suggested that roadside sobriety tests should be used as a more reliable way to determine if a given driver is impaired or not. This suggestion brings to mind the sobriety tests that are administered to drivers who are suspected of driving under the influence of alcohol.

How then can a police officer distinguish between impairment due to alcohol and impairment due to cannabis consumption? A blood test administered once a person fails the sobriety tests can help to distinguish between impairment caused by cannabis and that caused by alcohol.

The findings of this commission bring to question the decision of the states that set a THC threshold to determine when a driver is impaired by cannabis.

For example, Colorado, Montana and Washington State put the threshold at 5ng/ml. Nevada put the limit at 2ng/ml while Pennsylvania set its limit at 1ng/ml. How were these limits arrived at?

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) and SinglePoint, Inc. (OTCQB: SING) applaud the commission for looking at the available scientific data and then making an objective decision without being influenced by what other states have done to define driving while impaired by cannabis.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The Mexican Secretary of Security and Citizen Protection took to Twitter on Monday (March 25) to ask citizens to share their opinions regarding whether recreational cannabis should be legalized in the country or not. The cabinet official oversees the federal police, intelligence services and prisons.

Less than 24 hours after the poll was initiated, 81 percent of all the respondents said that adult-use marijuana should be legalized while 19 percent said that it shouldn’t be legalized. More than 82,000 people had participated in this survey by that time, so those percentages should not be taken lightly.

It wasn’t immediately clear what the intention of the government was in doing the survey, and it is not clear what they will use the findings for. Whatever their reasons, the social media poll can be seen as further proof that the federal government in Mexico is serious about reforming its marijuana laws.

Last year, one senator tabled a bill to legalize recreational marijuana in the country. That senator is now the Interior Secretary of the country.

Shortly afterwards, the Senate released a report listing the different aspects that lawmakers should keep in mind when drafting a bill to legalize recreational marijuana. These included product labeling, age-restrictions, modes of consumption to be allowed, THC limits, and so many others.

That report didn’t make any specific recommendations about what the law should stipulate. Instead, it outlined the different areas that the proposed legislation should cover. This report was based on what other jurisdictions around the world have looked at while drafting their own marijuana legalization laws.

It should also be remembered that in 2018, Mexican cabinet members visited Canada in order to talk to officials there about the Canadian recreational cannabis legalization program.

This cabinet visit took place shortly before the Supreme Court in Mexico made a ruling that it was unconstitutional to ban the consumption of marijuana by adults.

The Twitter poll may therefore be regarded as something that will further galvanize the lawmakers to discuss the legalization bill with the knowledge that the public is solidly in support of the legislation.

However, it should be noted that social media polls cannot in any way be seen as representative or scientific, so any findings collected from such a poll may not stand up to rigorous scrutiny. Nevertheless, the cannabis industry, including Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and Sugarmade, Inc. (OTCQB: SGMD) regard the poll by a cabinet member as a signal that robust discussions are taking place to decide what form cannabis legalization in Mexico takes.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
Analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market.

• $22 billion-plus CBD market could eclipse broader cannabis market
• Growing consensus about health benefits backed by clinical work, personal endorsements
• CBD found in everything from beverages and dog treats to pharmaceuticals and wellness products

The opening of the CBD floodgates represents a huge opportunity for plant-based wellness and health-product developers such as Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile) and Green Growth Brands Inc. (OTCQB: GGBXF) (CSE: GGB), a lifestyle-oriented developer of cannabis and CBD consumer products. Similarly, some of the fastest-growing producers in the industry today, such as Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) and HEXO Corp. (NYSE: HEXO) (TSX: HEXO) all stand to benefit as the rising tide of the CBD market continues to see tremendous growth for a number of reasons.

To view the full editorial, visit http://cnw.fm/J1Fh0

To hear the CannabisNewsAudio version, visit http://cnw.fm/aN7GS

About Wildflower Brands

Wildflower Brands is headquartered in Vancouver and is dedicated to building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts. For more information, visit the company’s website at www.WildflowerBrands.co.

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://cnw.fm/WLDFF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Medical cannabis has been available in Ohio for about three months now, but the latest data shows that the 20,000 people registered on the program haven’t displayed much eagerness to buy all the cannabis available at dispensaries. Here are some reasons that could explain this lack of buyer enthusiasm.

High Product Prices

One major concern for Ohio medical cannabis patients is the high prices being levied for medical cannabis products. On average, an ounce of cannabis costs $470. This is twice the cost of medical cannabis in Michigan.

Why is Michigan significant in this case? Patients from Ohio and other states can use their medical cannabis cards to buy medical marijuana in Michigan. It is therefore regrettable that the products in Ohio are so expensive.

This high cost can be attributed to the high licensing fees levied, as well as the rigid product packaging and testing requirements imposed by the state.

Dispensaries Aren’t Evenly Distributed

Ohio licensed 56 dispensaries. So far, only nine have opened their doors to patients. Unfortunately, all those nine are found on the Eastern side of the state.

Patients must therefore drive for several hours in order to find a dispensary and buy the products they need. Obviously, not many of the patients have felt the urge to endure those long drives.

Sales may therefore remain lukewarm until more dispensaries open closer to the patients who need the products available.

Unfavorable Possession Rules

Another major factor that can explain why patients aren’t buying as much medical cannabis as the state would expect is that the rules restrict a patient to just 90-days’ worth of cannabis. However, the clock starts ticking on those 90 days from the time you get your prescription from a doctor.

This means that every day you take without buying the maximum amount of cannabis allowed reduces the quantity that you will buy when you eventually visit a dispensary.

For example, a patient who goes to a dispensary 60 days after getting their prescription can only buy medical cannabis that can last a maximum of 30 days.

Furthermore, the high cost of cannabis means that patients may find it hard to buy a large amount of cannabis during one visit to a dispensary.

A Limited Range of Products

The law bars patients from smoking medical marijuana. However, only dried flower is currently available in the dispensaries that have so far opened.

This means that patients who want cannabis oil, tinctures, patches, lotions and edibles cannot spend any money on cannabis products until what they want is available.

All these issues show that the medical marijuana program has gotten off to a rocky start. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) hope that the medical cannabis program matures quickly so that each patient can get what they want at an affordable cost.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

A bill sponsored by Rep. Bob Morgan seeks to make the pilot medical program in Illinois permanent. The bill also has provisions to include more qualifying conditions for the program.

The pilot program was approved in 2013 and lawmakers expanded as well as extended its duration to mid-2020.

Under the existing program, patients who suffer from one or more of the 40 qualifying conditions can buy a maximum of 2.5 ounces of medical cannabis every fortnight as long as a doctor approved their enrollment on the program.

It should be noted that law enforcement agencies haven’t raised any red flags about the program. For example, no reports have emerged of people using medical cannabis when they aren’t licensed to do so.

In contrast, the program has received a lot of praise from patients because those patients have been able to wean themselves off of stronger prescription drugs as a result of using medical cannabis.

Currently, about 58,000 people are registered on the medical marijuana program. However, this number is small when compared to the number of patients on the medical cannabis programs of other states.

One of the reasons for the low enrollment in Illinois is that chronic pain isn’t one of the qualifying conditions for which someone can enroll on the program.

This is set to change if Morgan’s bill becomes law. Chronic pain, migraines, autism, irritable bowel syndrome, osteoarthritis and several other conditions will be added to the list of qualifying conditions.

The bill also wants to make it possible for doctors to receive payment from patients or medical marijuana businesses. This payment is necessary because a lot of responsibility is given to doctors and yet no compensation was prescribed for the services that they offer to keep the medical marijuana program running.

However, the bill clearly states that doctors will not be paid for making medical cannabis referrals. Instead, they can be paid for conducting medical cannabis research.

Notably, the bill tabled by Rep. Morgan also wants to put in place mechanisms for veterans to access medical marijuana. Veterans need special attention in this regard because marijuana is still illegal under federal law, so Veterans Affairs doctors cannot prescribe it.

Morgan’s bill wants medical marijuana to be available to veterans as an alternative to the opioids that the veterans take to deal with chronic pain.

If all goes according to plan, the bill introduced by Morgan may be passed by fall. MustGrow Biologics Corp. and Net Element, Inc. (NASDAQ: NETE) hope that Rep. Bob Morgan’s bill sails through so that patients aren’t left wondering what will happen to them once the pilot medical cannabis program runs its course.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

In just 4 weeks, industry leaders will gather in Las Vegas for Cannabis Conference. March 31 is the final day to register for the conference online.

 WHO: Produced by the award-winning publications Cannabis Business Times and Cannabis Dispensary, Cannabis Conference 2019 is the only North American conference focused exclusively on cultivators and dispensaries. Conference attendees will have the ability to get up close and personal with many of the brightest minds in the cannabis industry.

WHAT: Cannabis Conference 2019 will host 3,000+ industry professionals from 26 different countries. 40+ sessions will be led by 90+ cultivation, retail and business experts; and a sold-out expo floor spanning 70,000 square feet will showcase over 125 technology and solutions providers serving cannabis cultivation and dispensary businesses.

WHERE: Cannabis Conference will take place in Las Vegas, Nevada at the Westgate Resort & Casino, 3000 Paradise Rd, Las Vegas, NV 89109.

WHEN: April 1-3, 2019. Registration opens at 8:00 a.m. on Monday 4/1. All-Access Pass registrants will gain special admission to pre-show workshops on a variety of topics including expansion and franchising, biological control, supply chain management, extraction facility design, cannabis disease prevention and more.

WHY: Cannabis Conference 2019 will bring together more than 90 world-class speakers, including Jeremy Plumb, John Cochran, Leif Abel, Laura Day, Scott Reach, Wanda James, Sjoerd Broeks and more. In-depth educational programming completely focused on cultivation and/or dispensary business’s success will be offered. There will be daily networking and opportunities where attendees can personally meet with professionals from both ends of the supply chain. Pre-show workshops and post-show video access will be available to All-Access Pass registrants. The expo floor at Cannabis Conference will be more than 70,000 square feet and will showcase the industry’s latest cutting-edge technologies and solutions. This premier industry event will offer unprecedented insights into the dynamic global cannabis industry at a time when business growth and legalization are intersecting in new markets almost every day.

Note to Editors: Press passes are available. Interviews can be arranged with the editors of Cannabis Business Times and Cannabis Dispensary (which produce the Cannabis Conference), as well as with conference speakers. Speaker headshots and images from previous Cannabis Conference events are available.

Media contact: Brooke Bogdan, 216-393-0332 or [email protected]. Find more information on Cannabis Business Times’s Facebook, Twitter, Instagram, and LinkedIn. More information is also available on Cannabis Dispensary magazine’s Facebook, Twitter, Instagram, and LinkedIn. Visit www.cannabisconference.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

This article contains Third-Party Content submitted by third parties, including articles submitted through the CNW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of CNW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and CNW does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by CNW providing you with this internet portal that makes accessible to you the ability to view third-party content through the CNW site, CNW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. CNW expressly disclaims liability relating to such third-party content. CNW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, CNW reserves the right to remove third-party content at any time in its sole discretion.

CannabisNewsWire Editorial Coverage: Analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market.

• Growing CBD market could eclipse broader cannabis market
• Consensus about health benefits backed by clinical work, personal endorsements lead to heightened interest
• CBD found in vast array of new products

As CBD moves into the mainstream, opportunities are likely to grow exponentially for a variety of companies, including plant-based health and wellness product developer Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile). Canadian company Tilray Inc. (NASDAQ: TLRY) is riding the wave by acquiring Manitoba Harvest, the world’s largest hemp foods company. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) recently announced it has closed a billion-dollar equity investment from an outside company. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) just received a cultivation license from Health Canada for its facility in New Brunswick. Aphria (NYSE: APHA) (TSX: APHA) also received additional licensing approval from Health Canada, permitting the company to commence production in…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

After passing a medical marijuana law in December 2018, Utah has now engaged high gear in moving towards implementing the program. The state is currently looking for a software provider who will design a two-part system that will, in effect, run the entire medical cannabis program.

One part of the system will track each medical cannabis plant from the time it reaches eight inches tall to the point when it is bought by a patient registered to use medical marijuana in the state.

Tracking the plants is important because the state will be sure that legally grown weed isn’t being channeled to the black market.

The second part of the software will be used to enroll patients on the medical cannabis program, store information about the prescriptions issued by doctors and keep track of how much medical cannabis each patient is buying.

The state will have a big decision to make regarding whether one provider will be sufficient for the two components of the medical cannabis system or multiple providers should be sourced for the different aspects of the system.

State officials want to select the firms that will provide the software by May so that the second half of the year is devoted to selecting medical marijuana cultivators. The deadline for starting to receive applications from patients who want to use medical marijuana is March 1, 2020, but the officials want to start receiving applications earlier than that date, if possible.

However, eyebrows have been raised about the plan to allow law enforcement to access the system. Advocates are concerned that the police or any other law enforcement agency (state or federal) may abuse that access they are granted.

The state insists that law enforcement will only be allowed to confirm whether someone is authorized to possess medical cannabis or not. Other details, such as the qualifying condition for which a patient got approval to use medical cannabis, will be inaccessible to law enforcement.

The software program is expected to cost anywhere from $2 million to $5 million. This amount will cover the cost of building as well as running the system for its first five years of existence.

To put this cost into perspective, think about what Pennsylvania spent for a similar system. The state spent $10.4 million for building and operating its system for five years.

However, Nevada spent approximately $816,000 to acquire and operate a traceability system for its medical cannabis program for four years. Traceability covers just half of what Utah is seeking, but you can get a picture of how the costs compare.

Marijuana Company of America, Inc. (OTCQB: MCOA) and Medical Cannabis Payment Solutions (OTC: REFG) hope that the provider selected designs and implements a system that will not be plagued by the glitches that have disrupted medical cannabis programs in other states.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The process of legalizing recreational marijuana in New York has hit a major snag with the announcement that it isn’t included in the state budget for 2020. This means that it may now be harder to pass the legalization bill as a standalone bill.

Gov. Andrew Cuomo (D) has been pushing to have the bill included in the state budget for 2020, but it seems things haven’t gone his way.

The major issue in the way of legalization appears to be disagreements regarding how the program will be implemented. For example, the legislators are sharply divided about the way in which the taxes from recreational weed should be spent.

Another source of disagreement is the insistence by people of color that measures should be included in the law to avail economic opportunities in the industry to the racial groups, such as African Americans, which suffered the most during the war on drugs. Expunging criminal records isn’t enough, they say.

Even Cuomo admits that the task of passing the bill will be harder now that it isn’t included in the budget. However, the Governor is still optimistic that discussions on legalization will continue at a slower pace and a law may be in place this year.

Before this setback, many legislators had expressed reservations about the possibility of reaching a consensus in time to include marijuana legalization in the budget. Their fears just materialized, and cannabis legalization just got a little harder to attain.

The setback in New York State comes just days before neighboring New Jersey was expected to vote on a bill that would legalize recreational pot. However, that vote was called off on Monday (March 25), to the disappointment of marijuana advocates.

The New Jersey vote cancellation was a strategic decision by the Governor, the State Senate leader and the head of the Assembly. They opted to delay the vote so that they work to secure sufficient support for the bill, rather than insisting that the vote happens and the bill fails to get enough support.

You can now see how the situation in New York State is similar to what happened in New Jersey. Both processes have slowed or stalled because of insufficient support or disagreements among legislators despite the overwhelming public support for legalization.

Green Hygienics Holdings Inc. (OTCQB: GRYN) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) urge the legislators in New York State to listen to each other and reach a compromise for the good of the people in the state.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
Surging hemp market growth has created huge demand for hydroponic supplies.

• Demand for CBD is driving a rise in hemp cultivation, much of which is done indoors using hydroponic equipment.
• This hydroponic approach allows greater quality control over the cultivation process and the hemp.
• Acquisitions and expansion are needed for hydroponic companies to keep up with demand.

Hydroponic supplier Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) has been making swift moves to deal with this demand, acquiring other supply companies and outlets. Canadian company Tilray Inc. (NASDAQ: TLRY) has acquired the world’s largest hemp foods company, giving it a strong position in a customer-facing part of the sector. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has set up a new hemp extraction and product manufacturing facility in New York state. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has received a large boost in investment thanks to interest in the surrounding sector, providing fuel for future growth. Aphria (NYSE: APHA) (TSX: APHA) is looking beyond North America, with the acquisition of a European distributor.

To view the full editorial, visit http://cnw.fm/U7dK0

To hear the CannabisNewsAudio version, visit http://cnw.fm/45SsC

About Sugarmade, Inc.

Sugarmade, Inc. is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include BizRight, LLC, Athena United, CarryOutSupplies.com, and BudLife Cannabis Storage Solutions. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at www.cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

On March 25, the planned vote on a marijuana legalization bill in New Jersey was suddenly called off by both legislative houses in a move that disappointed cannabis advocates who had thought that the bill would sail through. Here are some possible reasons for the cancellation of the vote.

Insufficient Time to Convince Legislators

The legalization bill was released by the different committees less than a fortnight before a final vote was scheduled by the two houses.

This time was too little for advocates to convince legislators to support the bill. Consequently, Senate President Sweeney thought it wise to cancel the vote rather than take a risk and the bill fails to garner the required number of “yes” votes.

Strong Resistance Among Democrats

From the time Gov. Murphy made legalizing marijuana a priority of his term in office, there were a number of Democratic legislators that vowed not to support the legalization process.

These senators included Fred Madden (D-Gloucester), Richard Codey (D-Essex), Ronald Rice (D-Essex) and so many others. To compound this opposition, other Democratic senators joined those opposing the bill late during the legalization process.

This opposition from within the Democratic camp made it even more urgent to rally some Republican senators for the cause, but as earlier mentioned, there wasn’t enough time for this.

Last-Minute Changes Unsettled Some Legislators

Another possible reason why voting on the legalization bill was called off is because there were some changes that were made to the bill in the committees just before it was sent to be voted on by all legislators in the different houses. These changes weren’t agreeable to all supporters, especially in the state senate.

Of particular concern were changes that were introduced on matters of expunging the criminal records with respect to cannabis arrests and convictions.

Some legislators who would have voted for the bill were dismayed when they discovered that the threshold for possession was set at five pounds for those to benefit from the expungement provisions. This was unacceptable to these legislators and some decided to switch from supporting the bill to opposing it.

So, what happens next?

There is hope that the bill may be reconsidered for a vote before June 30 when the next budget of the state is due to be passed. If that doesn’t happen, then legalization may be delayed by another year or until another set of legislators is voted into office.

The cannabis industry, including Global Consortium, Inc. (OTC: GCGX) and Global Payout, Inc. (OTC: GOHE) hope that the current wave of support for cannabis legalization in the public and among the legislators results in a speedy passing of this bill.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The U.S. DEA (Drug Enforcement Agency) is looking for a contractor in Arizona to incinerate cannabis between the months of March and September. The contractor will be expected to burn cannabis at a rate of 1,000 pounds every hour.

The marijuana will be brought to the incineration facility from about 12 cities within Texas. While the agency isn’t certain about the way in which the marijuana to be burnt will be packaged, they predict that some of it will be in the form of tightly packed “bales” or ”bricks” weighing less than 60 pounds.

Some marijuana will be in plastic evidence bags, in aluminum foil, in packing tape, and so many other packing methods.

Needless to say, the DEA got its hands on this marijuana during its field operations against those who sell the drug on the streets, and other illegal activities.

The federal agency reveals that the selected contractor should be able to burn marijuana for eight hours straight on a daily basis and the incineration equipment is expected to have interlocks so that the process can be halted during an emergency.

The marijuana should be destroyed to an extent that standard analytical tests will be unable to detect any cannabis residues once the incineration process has been completed. The DEA will also conduct inspections to confirm that the substance has been destroyed to the required standard.

Additionally, the federal agency will have its representatives or staff present to witness the destruction process, and the facility should have a fence that is so high that onlookers cannot observe the destruction process from outside the facility.

The incineration facility is also expected to have CCTV cameras recording every step of the process. The DEA says that they reserve the right to access the CCTV footage in order to ascertain that the burn was conducted in accordance with the specifications provided, and that the representatives of the agency are safe in that environment.

The contractor selected should have employees who undergo background checks in addition to drugs tests annually.

While the notice has been published to receive applications from interested contractors, the DEA seems to already have an entity in mind that they plan to award this contract. Tuscon Iron & Metal is located within close proximity to the towns where the DEA keeps all the marijuana it confiscates in Arizona. The DEA mentions this company as a potential “sole source” provider of the service they seek.

Golden Developing Solutions, Inc. (OTC: DVLP), Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) and the entire cannabis industry congratulate Tuscon Iron & Metal for positioning itself in such a powerful way that the DEA can consider them as a sole source of their incineration requirements in the area.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

John Cochran, Chief Operating Officer of Harvest Health & Recreation, (CSE: HARV) (OTCQX: HRVSF) (“Harvest”), will deliver the Welcome Keynote, “Tapping the Beverage Market Boom,” at Cannabis Conference 2019, April 1-3, in Las Vegas, Nev.

“While alcohol and cannabis differ in many ways, the regulatory framework and consumer trends shed light on the future of the plant in this country and around the world,” said Cochran, who is the former CEO of multistate cannabis company Loudpack Inc., former CEO of Pabst Brewing Company, and former president and COO of Fiji Water Company. “I’m excited to share the lessons I’ve learned after decades at some of the largest beverage and cannabis companies in the world with attendees of Cannabis Conference.”

Harvest is a vertically integrated cannabis company with licenses for more than 140 retail, cultivation, manufacturing and distribution facilities across 12 states. In his Keynote, Cochran will also explore Harvest’s value chain and frameworks for considering profitable, scalable solutions and the importance of communicating those shifts to investors.

“John’s experience at leading beverage brands and his role at Harvest Health & Recreation can shed light on key opportunities in today’s cannabis industry. We’re excited for our attendees to have the opportunity to learn from him,” said Noelle Skodzinski, Cannabis Conference editorial director.

This year, 3,000+ industry professionals from 26 different countries are expected to attend Cannabis Conference; 40+ sessions will be led by 90+ cultivation, retail and business experts; and a sold-out expo floor spanning 70,000 square feet will showcase technology and solutions providers serving cannabis cultivation and dispensary businesses.

“Cannabis Conference is the most valuable educational event we have brought to market for plant-touching cannabis businesses. What a fitting way to kick off the week with a Keynote from John,” said Jim Gilbride, group publisher, who oversees the Cannabis Conference.

About Cannabis Conference:
Cannabis Conference, April 1 – 3 at the Westgate Las Vegas Resort & Casino, is produced by Cannabis Business Times and Cannabis Dispensary, and is the only North American conference focused exclusively on cultivators and dispensaries. The final day to register online (at CannabisConference.com) is March 31. “To request a press pass, email [email protected].

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

This article contains Third-Party Content submitted by third parties, including articles submitted through the CNW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of CNW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and CNW does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by CNW providing you with this internet portal that makes accessible to you the ability to view third-party content through the CNW site, CNW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. CNW expressly disclaims liability relating to such third-party content. CNW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, CNW reserves the right to remove third-party content at any time in its sole discretion.

CannabisNewsWire Editorial Coverage: Analysts at Brightfield Group see CBD (cannabidiol) gobbling up a sizeable chunk of a projected $100 billion nutraceuticals 2022 U.S. market.

• $22 billion-plus CBD market could eclipse broader cannabis market
• Growing consensus about health benefits backed by clinical work, personal endorsements
• CBD found in everything from beverages and dog treats to pharmaceuticals and wellness products

The opening of the CBD floodgates represents a huge opportunity for plant-based wellness and health-product developers such as Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile) and Green Growth Brands Inc. (OTCQB: GGBXF) (CSE: GGB), a lifestyle-oriented developer of cannabis and CBD consumer products. Similarly, some of the fastest-growing producers in the industry today, such as Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) and HEXO Corp. (NYSE: HEXO) (TSX: HEXO) all stand to benefit as the rising tide of the CBD market continues to see tremendous growth for…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

David Klein, the founder of the famous Jelly Belly candy, recently announced that he will be launching a new line of jelly beans that contain cannabidiol (“CBD”). The announcement was recently discussed in an article authored by David Aaro, on Fox News titled ‘Jelly Belly creator introduces CBD-infused jelly beans’. Klein has created a new company, Spectrum Confections, which is adding CBD oil to 38 flavors such as toasted strawberry cheesecake, marshmallow, pina colada and mango. The candies will not include THC, the main active ingredient in cannabis. “The jelly bean is perfect for the proper dosage [of CBD],” David Klein stated in a recent interview with Cannabis Aficionado (http://cnw.fm/0u9OW). “We are putting 10 ml in each [bean]. If people want a small dose, they eat one. If they want 20 ml, they can eat two,” and so on. “They can decide what their proper dosage is.”

To view the full article, visit http://cnw.fm/p1LGo

About Fox News

FOX News operates the FOX News Channel (“FNC”), FOX Business Network (“FBN”), FOX News Radio, FOX News Headlines 24/7, FOXNews.com and the soon to launch OTT platform, Fox Nation. FOX News also produces FOX News Sunday on FOX Broadcasting Company and FOX News Edge. A top five-cable network, FNC has been the most watched news channel in the country for more than 16 years. According to a 2018 Research Intelligencer study by Brand Keys, FOX News ranks as the second most trusted television brand in the country. Additionally, a Suffolk University/USA Today survey states Fox News is the most trusted source for television news or commentary in the country, while a 2017 Gallup/Knight Foundation survey found that among Americans who could name an objective news source, Fox News is the top-cited outlet. FNC is available in 90 million homes and dominates the cable news landscape while routinely notching the top ten programs in the genre. For more information, visit www.FoxNews.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
Following the passing of the 2018 Farm Bill, CBD sales have continued their massive growth in the United States and beyond.

• Cannabidiol (CBD), a chemical found in cannabis, has seen a huge growth in sales over the past few years.
• CBD can be derived from hemp, and the passing of a new farm bill in the States makes this form of cultivation legal at a federal level.
• This forms part of wider growth in the cannabis market, as companies expand their operations in North America and even beyond.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) is among the companies benefiting from this market, with an increase of more than 300 percent in online sales for its CBD products last year. Some companies are specializing in particular niches, such as The Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) with its focus on sustainable organic plants. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) is making moves into Europe, with cannabis oil sales in Germany and investment in a Portuguese grower. Green Growth Brands Inc. (OTCQB: GGBXF) (CSE: GGB) is launching new products and opening its own shops across the United States. And HEXO Corp. (NYSE: HEXO) (TSX: HEXO), which recently expanded from medical cannabis into the recreational space, has seen gross revenue increase more than 1,000 percent as part of this rising tide.

To hear the CannabisNewsAudio version, visit http://cnw.fm/Wn9uB

To view the full editorial, visit http://cnw.fm/HdIh7

About Wildflower Brands

Wildflower Brands is headquartered in Vancouver and is dedicated to building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts. For more information, visit the company’s website at www.WildflowerBrands.co.

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://cnw.fm/WLDFF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The lack of data on the long-term safety of cannabidiol (“CBD”) oil was recently emphasized in an article authored by Nicole Saphier, M.D., on Fox News titled ‘CBD oil is the new rage among millennials. But, as a doctor, here’s what I worry about’. Among other highlights, the article reminds readers that even though the limited and short-term data on CBD oil is promising, there is not any long-term data yet to further support the safety and effectiveness as a treatment to various ailments. Although there is scientific evidence demonstrating that CBD has FDA-proven benefits for treating epileptic seizure disorders and is now permitted to be prescribed by a physician, Dr. Saphier cautions that research regarding numerous other hyped health claims is still lacking (http://cnw.fm/mA8uV). Dr. Saphier urges all patients to err on the side of caution while the long-term data is pending, and to follow their medical doctors’ recommendations.

To view the full article, visit http://cnw.fm/sjTw7

About Fox News

FOX News operates the FOX News Channel (“FNC”), FOX Business Network (“FBN”), FOX News Radio, FOX News Headlines 24/7, FOXNews.com and the soon to launch OTT platform, Fox Nation. FOX News also produces FOX News Sunday on FOX Broadcasting Company and FOX News Edge. A top five-cable network, FNC has been the most watched news channel in the country for more than 16 years. According to a 2018 Research Intelligencer study by Brand Keys, FOX News ranks as the second most trusted television brand in the country. Additionally, a Suffolk University/USA Today survey states Fox News is the most trusted source for television news or commentary in the country, while a 2017 Gallup/Knight Foundation survey found that among Americans who could name an objective news source, Fox News is the top-cited outlet. FNC is available in 90 million homes and dominates the cable news landscape while routinely notching the top ten programs in the genre. For more information, visit www.FoxNews.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Surging hemp market growth has created huge demand for hydroponic supplies.

• Demand for CBD is driving a rise in hemp cultivation, much of which is done indoors using hydroponic equipment.
• This hydroponic approach allows greater quality control over the cultivation process and the hemp.
• Acquisitions and expansion are needed for hydroponic companies to keep up with demand.

Hydroponic supplier Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) has been making swift moves to deal with this demand, acquiring other supply companies and outlets. Canadian company Tilray Inc. (NASDAQ: TLRY) has acquired the world’s largest hemp foods company, giving it a strong position in a customer-facing part of the sector. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has set up a new hemp-growing facility in New York state, using hydroponics to help it meet growing demand. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has received a large boost in investment thanks to interest in the surrounding sector, providing fuel for future growth. Aphria (NYSE: APHA) (TSX: APHA) is looking beyond…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Dozens of former National Hockey League (NHL) players will receive cannabis as part of a study to investigate the effects of CBD on brain injuries.

Dr. Charles Tator, a neurosurgeon and concussion expert, says that his team hopes that CBD will exhibit a therapeutic effect on the former players who suffer from chronic pain and other symptoms of repetitive brain injury.

For this study, the researchers recruited about 100 former NHL players to participate as research subjects.

Half of those people will receive a placebo while the rest will be given CBD. All the study subjects will continue taking any other medication that they were taking for their symptoms.

The researchers will observe these individuals for 12 months and assess whether CBD had any impact on their illnesses. The research is slated to begin this summer.

This research is being conducted in order to find an alternative to the addictive and harmful opioids that athletes take for chronic pain and the other symptoms resulting from the head injuries that they sustain during their playing days.

It is estimated that nearly two out of ten people who sustain sports-related concussion end up with chronic symptoms after the concussion. These symptoms include chronic headaches.

The players also develop emotional problems, such as depression and anxiety. Many of these former players live a miserable life once they are out of the limelight because little attention is directed to them if they aren’t actively playing.

It is such realities that have prompted the NHL Alumni, the Canadian marijuana company Canopy Growth and Neeka Health to team up and conduct this research.

The researchers hope that the complex and multidimensional study that they have taken on will provide valuable insights into how CBD interacts with the behaviors and brains of former NHL players struggling with the symptoms linked to the aftermath of suffering concussions.

This particular study isn’t the first in this area. For example, an earlier study conducted by a team of researchers from Miami University found that a combination of CBD and an anesthetic (NDMA) was effective in improving the condition of test animals that had brain injuries. This team of researchers is now conducting a human study to see what parallels emerge between their animal study and the human one.

The entire cannabis industry, especially FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) and Generation Alpha, Inc. (OTCQB: GNAL), hopes that the studies confirm that cannabis is not only viable but also better at treating the post-concussion symptoms.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Rolling Greens, a golf course found near Smith Falls in Ontario, is set to take the “green” in its name to a whole new level by becoming the first golf course to allow cannabis smoking on its grounds.

Gordon Weiske, the Director of Entertainment at the golf course, revealed that while other people were clamoring to acquire licenses to grow or retail cannabis, Rolling Greens decided to be different and become a golf course with a cannabis theme.

He says that they decided to allow golfers to enjoy cannabis while playing the game. While strict rules prevent the consumption of cannabis in public, golf courses are free to make their own rules. Besides, smoking is allowed on golf courses, and cannabis smoking is usually allowed in places where one can smoke a cigarette.

The management of Rolling Greens therefore decided to take a different approach from other golf courses that banned smoking marijuana on their grounds. Rolling Greens felt that there was no reason to ban cannabis smoking if cigarette smokers are allowed on the property.

Currently, there is no cannabis sold at the golf course, so users have to carry their own cannabis products if they wish to enjoy cannabis at the golf course.

Rolling Greens doesn’t just want to be known as a golf club where one can smoke weed. They have set their eyes on bigger things.

For example, they intend to set up an age-restricted entertainment park where a mini-putt, drive-in movie theatre and virtual reality games will be available.

Such a facility will be easy for them to create because the golf course sits on a massive 164 acres of land. Space is certainly not one of the problems they face.

The golf course also has plans to partner with cannabis producers who will then set up their own sponsored theme on one of the holes of the golf course.

It should be noted that this golf club hasn’t always been called Rolling Greens. This name was introduced as part of a rebrand of the facility after it was acquired by new owners. Previously, the golf course was called Lombard Glen Golf and Country Club.

In effect, Rolling Greens is approximately two months old. The club intends to host a soft launch on April 20 to give clients and fans a chance to sample what the facility has to offer. Bigger launch events will also be held over the coming months.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and ChineseInvestors.com (OTCQB: CIIX) congratulate Rolling Greens upon their trailblazing activities that are widening the boundaries of the cannabis industry while creating new opportunities.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
Drinks infused with cannabis-derived cannabidiol (CBD) are in a prime position to bring disruption to the beverage sector.

• The growing consumer interest in hemp-derived CBD as a health supplement along with the recent passing of the Farm Bill has spawned a growing interest in CBD-infused drinks.
• The ever-increasing global trend to legalizing cannabis is also creating demand for “harder” beverages derived from marijuana
• Big alcohol companies have taken a particular interest in investing in cannabis producers.
• The relationship is also working in an inverse direction, with CBD producers recruiting experienced beverage executives to help launch new products.

Corporate interest in building a cannabis-infused beverage profile demonstrates the level of potential growth for such an industry, with key developments being made across multiple channels. To address the needs of the wellness-oriented consumer, Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) (PHVAF Profile) has created a line of active hemp extract (CBD)-infused drinks that are just starting to hit store shelves and is expected to be distributed to a thousand retail outlets in Q2. In the adult beverage sector, Constellation Brands Inc. (NYSE: STZ) has made a $4 billion investment in Canopy Growth Corp. (NYSE: CGC) (TSX: WEED), fueling research into cannabis drinks which suggests a proactive approach to addressing the potential sales impact in markets where consumer use of marijuana is legal. The Canadian business unit of Molson Coors Brewing Company (NYSE: TAP) has also made a deal with a cannabis producer to create beverages for that market. In the health supplements sector, Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB), which markets hemp-derived CBD oil, has recruited a former Coca-Cola executive to bring beverage sector expertise into the company.

To view the full editorial, visit http://cnw.fm/y0fZt

To hear the CannabisNewsWire Audio version, visit http://cnw.fm/lOhW7

About Phivida Holdings Inc.

Phivida Holdings Inc. is headquartered in Vancouver, BC with operations in San Diego, CA. Phivida is a premium functional food and beverage company focused on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses organic active hemp extract into a variety of premium beverages and clinical products for everyday health. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages, and a focus on holistic health and wellness. The mission is to help reduce the world’s dependence on pharmaceuticals and provide food and beverage choices that allow customers to live a balanced healthy lifestyle. For more information, visit the company’s website at www.Phivida.com.

NOTE TO INVESTORS: The latest news and updates relating to PHVAF are available in the company’s newsroom at http://cnw.fm/PHVAF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

A drafting committee in the Thai Legislative Assembly is working on a bill to legalize marijuana in the state. However, many people are wondering whether the country is ready for this move. An analysis of the factors on the ground shows that the road to legalization has a lot going for it while some obstacles remain, as explored in the discussion below.

Why It May Be Time for Legalization

A long history of cannabis use. Cannabis had been used for centuries in Thailand before it was outlawed in 1934. Laborers had for long used it to relax their sore muscles while expectant mothers used it to ease labor pains. The plant was also used as a cooking ingredient. These deep roots of cannabis use also gave the industry the word “bong” derived from Thai. This long history of use therefore makes the legalization of cannabis a no-brainer for this country.

The locals are experts in cultivating the plant. The benefit of the long history of cannabis use in Thailand has also resulted in generations of expert cannabis cultivators in the country. The locals are so good at this that they can identify a seed that will grow into a male plant! Legalization would allow these experts to practice their craft and earn from it.

Thailand is home to a unique cannabis strain. Thailand has a unique cannabis sativa strain that is sought after across the world because of its high THC content. This strain has a citrus aroma and it gives a high that doesn’t cause the user to be lethargic or drowsy. Legalization can allow this gift of nature to be exploited commercially.

But, There Are Roadblocks…

U.S. influence may delay legalization. Thailand has deep ties with the U.S. spanning decades. In fact, the banning of cannabis in 1934 was a result of U.S. pressure on the country. The U.S. Drug Enforcement Agency (DEA) even maintains an office in the country. As things stand at the federal level in the U.S., it would be expecting too much for one to think that the U.S. will not try to influence the process of discussing whether marijuana should be legalized or not.

Concerns over foreign firms. The road to legalization is likely to be bumpy as local firms jostle with foreign entities for control of the cannabis industry. Already, a storm is brewing about pending patents that have been filed by foreign companies. Locals see this as an attempt to lock them out of the industry, and they aren’t taking it lying down. The bill being drafted may stall while a way out of this storm is found.

All in all, global trends and the need to boost the agriculture-based economy of Thailand are likely to provide the momentum needed to pass medical cannabis legislation quickly in order to take advantage of the opportunities available.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) hope that any stumbling blocks can be resolved quickly so that the people of Thailand can enjoy the economic and medical benefits that the marijuana industry has to offer.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Two senators in Pennsylvania have drafted a bill to legalize recreational marijuana in the state, and they are now seeking cosponsors for their initiative.

State Sen. Sharif Street (D-Philadelphia) and Sen. Daylin Leach (D-Montgomery) have drafted the bill that reads like a dream come true for any marijuana advocate.

The bill intends to allow adults who are 21 or older to grow a maximum of six mature cannabis plants at home for their own use.

Home delivery of marijuana and its products will also be legal if the bill is enacted.

While it would be illegal to consume cannabis in public, the legislators included provisions that would permit the opening of marijuana consumption lounges where adults can go and indulge.

SB 350 goes further to suggest that not only will minor marijuana convictions and arrests be expunged from people’s criminal records, all individuals on similar charges who are serving time in Pennsylvania jails will be released as well. This goes far beyond what other states have done after legalizing recreational weed.

The bill also touches on where the tax revenue from recreational marijuana will be spent. Sens. Sharif and Leach propose that most of the taxes collected from the industry should go to revamping the public schools in the state.

The taxes generated may be considerable if the projected $600 million in sales for the first year materializes and increases in the subsequent years.

Some of the states that have legalized recreational marijuana have failed to invest cannabis taxes in social services because the funds went to meeting the costs of regulation and law enforcement.

The Pennsylvania Senators want to change that trend by including provisions on tax expenditure in the cannabis law so that there will be no risk of diverting the tax revenue to other expenditure areas.

Senator Sharif Street explains that the legalization of marijuana would help to address the opioid crisis in the state. He cites research data from other states showing that opioid use has reduced by about 33 percent after the legalization of medical marijuana.

While Gov. Tom Wolf is cautiously supportive of cannabis legalization, not everyone is ecstatic about the possibility.

For example, Jake Corman, the Republican Majority Leader in the Senate, says legalizing marijuana is “reckless and irresponsible.” He has gone further to vow that he will do whatever he can to stop any legalization bill from passing.

Cannabis advocates therefore have their work cut out for them if they want to see the bill become law. Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) and TransCanna Holdings Inc. (CSE: TCAN) look forward to hearing vibrant debates about the issues related to cannabis legalization before a decision is made for the good of all Pennsylvanians.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
The growth of the hemp sector is having a beneficial effect for both hemp companies and hydroponic suppliers.

• The growth of hemp more than doubled in the United States last year
• More companies are moving to produce hemp, causing a surge in demand for cultivation and hydroponic supplies
• Shortages are particularly acute relative to the hemp micropropagation and hemp cloning supplies as the spring planting season looms

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) via its pending acquisitions is poised to accelerate its growth rate as a result of this hemp cultivation boom, along with other leading companies. Tilray Inc. (NASDAQ: TLRY) has been expanding through the acquisition of other companies and a move into Europe, with a successful harvest in Portugal. Canopy Growth Corp. (NYSE: CGC) (TSX: WEED) is using outside investment to expand from Canada to New York and to develop CBD-infused drinks. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has also seen substantial outside investment thanks to growing faith in hemp. Aphria Inc. (NYSE: APHA) (TSX: APHA) has even faced a hostile takeover attempt as some companies look for ways to force their way into greater influence over a growing sector.

To hear the CannabisNewsAudio version, visit http://cnw.fm/ry0U3

To view the full editorial, visit http://cnw.fm/opiQ4

About Sugarmade, Inc.

Sugarmade, Inc. is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include BizRight, LLC, Athena United, CarryOutSupplies.com, and BudLife Cannabis Storage Solutions. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at www.cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Multifaceted financial news and publishing company CannabisNewsWire (“CNW”) today announced that it will serve as an official distribution partner for the O’Cannabiz Conference and Expo, Canada’s premier cannabis industry event to be held at Toronto’s International Centre from April 25 through April 27, 2019. The event will feature a wide range of industry-related panel discussions, timely cannabis topics, and offer access to over 400 exhibitor booths and B2B networking opportunities. “The O’Cannabiz Conference and Expo is truly a must-attend event that attracts the industry’s most exciting players in the cannabis space. CannabisNewsWire is proud to leverage its expertise and expansive distribution network to help maximize awareness of the incredible innovations and opportunities being presented in this rapidly evolving consumer marketplace,” CNW Director of Syndicated Communications Christopher Johnson said in the press release. “The “O’Cannabiz Conference and Expo promises to be an outstanding cannabis networking event, providing topical speakers and relevant breakout sessions for every segment of this expanding industry.”

To view the full press release, visit http://cnw.fm/t7iTC

About The O’Cannabiz Conference and Expo

The O’Cannabiz Conference and Expo is a gathering of the complete Canadian and International industry conducting high level networking under one roof. It is a full-spectrum cannabis B2B event that connects thousands of expert companies and brands integrated in the full 360 degrees of the industry. These include: lighting, nutrients, greenhouse construction and supplies, peer-reviewed agri-practices, lifestyle, medical and legal issues, marketing, the hiring of professionally trained growing staff, best financial and investment advice, quality control and market analyses. It is, in short, a buffet of best-business practices. And it’s your best opportunity to source… shop… network… and grow. To learn more about the O’Cannabiz Conference and Expo including how to purchase tickets, become a sponsor or reserve a booth, visit: https://ocannabiz.com

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Following the passing of the 2018 Farm Bill, CBD sales have continued their massive growth in the United States and beyond.

• Cannabidiol (CBD), a chemical found in cannabis, has seen a huge growth in sales over the past few years.
• CBD can be derived from hemp, and the passing of a new farm bill in the States makes this form of cultivation legal at a federal level.
• This forms part of wider growth in the cannabis market, as companies expand their operations in North America and even beyond.

Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF Profile) is among the companies benefiting from this market, with an increase of more than 300 percent in online sales for its CBD products last year. Tilray Inc. (NASDAQ: TLRY) is expanding with its acquisition of hemp foods company Manitoba Harvest. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) announced revenue for its fiscal third quarter rose more than 280 percent compared to a year ago. In December, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced that tobacco company Altria would be taking a $1.8 billion stake in the company. And Aphria (NYSE: APHA) (TSX: APHA) has just completed expansion projects that allows it to…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Ask anyone how they store their cannabis and you are likely to hear that they place it in an airtight plastic container stored away from direct sunlight. While this has been the norm for cannabis storage, new research suggests that such a method may not preserve the ingredients of your valuable stash for long.

The Italian study compared how THC content was preserved if cannabis was stored in four different ways for 100 days.

First, the researchers looked at what would happen to cannabis if it were stored for 100 days in a bright room at room temperature. This method of storage resulted in a 13 percent drop in the THC content of the cannabis.

The researchers also looked into what would happen to the THC content of cannabis that has been stored in a dark room at room temperature. The cannabis lost 11 percent of its THC content.

How do most processors store their cannabis? You guessed right, in a dark room at room temperature. These manufacturers may be slapping themselves in the face as they read this!

Next, the researchers looked at what would happen if a batch of cannabis was stored inside a refrigerator whose temperature was maintained at 4°C. There was a substantial reduction in the drop of THC using this method of storage.

The researchers then upped the ante and kept some marijuana in a freezer for 100 days. The temperature inside the freezer was maintained at -20°C. Tests revealed that there was no noticeable change in the THC content if the cannabis was stored in the freezer.

The researchers concluded that the best way to store cannabis in order to preserve its constituents was by freezing it. Storage in an airtight container in a dark room only works for short-term storage, they added.

The researchers also revealed that the CBD content of cannabis barely changes over time regardless of how you choose to store the marijuana. People who have no interest in THC shouldn’t therefore fret about how they keep their cannabis products.

However, the findings of this study should not be generalized as applicable to all the attributes or components of cannabis. For example, the study didn’t look into how the flavor or scent of cannabis was affected by the four storage methods investigated.

As you wait for research to be done on that, you can conduct your own little experiments to see how your perception of those attributes is affected when you store marijuana in different ways.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) welcome the insights that the study has shed on the different storage options for cannabis products.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

At the end of last week (March 14), lawmakers in Connecticut’s Assembly held a press conference at which they outlined a plan to legalize recreational marijuana in the state.

Rep. Michael D’Agostino, the chair of the General Law Committee, led the proceedings by giving a brief outline of the legalization plan.

He revealed that three major areas would be looked at when pushing the legalization plan forward. These are regulation, monetization and decriminalization. These three areas would be handled by different committees that are mandated to legislate in those areas.

D’Agostino added that the different committees would formulate various bills covering the cannabis legalization areas within their mandate before all those different bills are merged into one comprehensive bill. This will be after the committee bills are modified and agreed upon by all or most of the committee members.

The chair of the House Judiciary Committee (Rep. Steve Stafstrom) was next on the microphone and he talked about the three bills in his committee. One was focused on legalizing cannabis possession by adults 21 or older while also laying out how marijuana misdemeanor crimes would be expunged from the criminal records of residents.

A second bill in this committee looks at issues of impaired driving. One notable provision of this bill would see resources ring-fenced for training law enforcement to be experts at recognizing and screening drivers who may be under the influence.

The third bill for this committee will absolve employers from making any exceptions for employees who use weed. This means that if the bill becomes law, an employer may refuse to hire anyone who tests positive for marijuana, or fire an employee who is under the influence at work.

Rep. Jason Rojas, who sits on the Finance, Revenue and Bonding Committee spoke about the tax structure that Connecticut may adopt once recreational marijuana is permitted. He revealed that they were cautious and would propose a 20 percent tax so that Connecticut’s weed doesn’t cost more than what is available in Massachusetts where adult-use cannabis retails sales are already a reality.

Otherwise, people may buy recreational cannabis out-of-state instead of spending their money on Connecticut’s supply. The details of the tax structure would be made clearer in due course, Rojas added.

What came out strongly during the press briefing was that it is still early days to start talking timelines to the availability of recreational cannabis. A lot of work needs to be done to get the law in place, and this fact is brought home by the memory of what happened last year when legalization by legislative means failed after a bill that had been passed by a slim majority in the Appropriations Committee was stalled by the House Speaker until the end of the legislative session.

Hope is high this time round since Democrats control both chambers. Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) and Earth Science Tech, Inc. (OTCQB: ETST) wish the cannabis advocates good luck as they try to get the people of Connecticut to enjoy what the residents of 10 other U.S. states are already enjoying.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
CBD-infused beverages look set to hit the market in a big way in 2019.

• Cannabidiol (CBD) is widely used in health and wellness products after spectacular growth in recent years.
• Several companies are lining up to launch CBD drinks following legal changes in the United States and Canada.
• Integrating these new offerings into wider product lines is accelerating CBD’s race for mainstream attention.

Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) is one of the first to launch, with a CBD coffee coming in May and a CBD water in the works. The Alkaline Water Company Inc. (NASDAQ: WTER) (TSX.V: WTER), which is constantly growing its U.S. distribution network, plans to add a CBD bottled water to its range. The New Age Beverages Corporation (NASDAQ: NBEV) is adding CBD to its line of organic cold coffees and teas. Heineken (OTCQX: HEINY) has also entered the market by developing a cannabis-infused sparkling water through Lagunitas, its U.S. craft brewer. And the biggest investment in the overall cannabis space has come from Constellation Brands Inc. (NYSE: STZ), which has invested $4 billion in a Canadian cannabis company.

To view the full editorial, visit http://cnw.fm/7sDPj

To hear the CannabisNewsAudio version, visit http://cnw.fm/vmO3q

About Youngevity International Inc.

Youngevity International Inc., an emerging conglomerate operating in three distinct business segments including a vertically integrated coffee enterprise, a vertically integrated Hemp based product development enterprise including end to end processing, and a Direct Selling Enterprise that consists of an expanding portfolio of consumer brands developed with its in-house product development team and distributed by traditional and non-traditional channels, including a multi country direct selling network. For more information, visit the company’s website at www.YGYI.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Drinks infused with cannabis-derived cannabidiol (CBD) are in a prime position to bring disruption to the beverage sector.

• The growing consumer interest in hemp-derived CBD as a health supplement along with the recent passing of the Farm Bill has spawned a growing interest in CBD-infused drinks.
• The ever-increasing global trend to legalizing cannabis is also creating demand for “harder” beverages derived from marijuana
• Big alcohol companies have taken a particular interest in investing in cannabis producers.
• The relationship is also working in an inverse direction, with CBD producers recruiting experienced beverage executives to help launch new products.

Corporate interest in building a cannabis-infused beverage profile demonstrates the level of potential growth for such an industry, with key developments being made across multiple channels. To address the needs of the wellness-oriented consumer, Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) (PHVAF Profile) has created a line of active hemp extract (CBD)-infused drinks that are just starting to hit store shelves and is expected to be distributed to a thousand retail outlets in Q2. In the adult beverage sector, Constellation Brands Inc. (NYSE: STZ) has made a $4 billion investment in Canopy Growth Corp. (NYSE: CGC) (TSX: WEED), fueling research into cannabis drinks which suggests a proactive approach to addressing the potential sales impact in markets where consumer use of marijuana is legal. The Canadian business unit of Molson Coors Brewing Company (NYSE: TAP) has also made a deal with a cannabis producer to create beverages for that market. In the health supplements sector, Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB), which markets hemp-derived CBD oil, has recruited a former Coca-Cola executive to bring…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

As Illinois gears up to legalize recreational weed, a couple of bills have been tabled to protect state-chartered banks that decide to accept cannabis businesses as clients.

Under federal law, any money from cannabis businesses is regarded as drug money and banks that accept such money may be prosecuted by the federal authorities.

Consequently, most banks have been reluctant to do business with marijuana companies even if the allure of the huge sums of money that can be made from the cannabis industry is strong.

The past years have seen medical cannabis companies struggling to find a bank that is willing to take them on, and this is the situation that the newly introduced bills seek to fix.

Last year, medical cannabis sales generated approximately 136.5 million, and that figure is likely to grow to $224 million by 2022 once recreational sales begin. This is a huge amount of money to be lying around in sacks or safes within cannabis business premises.

More practical problems like how to pay employees and clients get worse once businesses don’t have access to banking services. For example, Ascend Illinois, one of the leading medical cannabis firms in the state, narrates how they had to take several days to drive cash to different vendors and employees around the state when the bank they were using withdrew its services.

Such a scenario creates a huge attraction to criminals who would want to lay their hands on such a huge amount of cash.

It is also hard for state authorities to track whether the cannabis companies are meeting their tax obligations if there is no paper trail to follow in order to verify the volume of sales each month.

The passing of state laws to shield local banks from federal prosecution can help to remove some of the concerns that the banks may have.

While it is true that no bank or credit union has so far been targeted by the feds for doing business with cannabis companies, a state law would protect the banks in the event that a change in policy at the federal level exposes the banks to risks.

For example, President Obama’s administration had passed a policy not to prosecute banks that do business with cannabis firms in states that legalized marijuana. However, President Trump’s administration rescinded that policy, effectively making it possible for federal law enforcement agencies to go after banks that accept marijuana businesses.

Such fluctuations in federal policy are what the bills introduced by state Sen. Tol Hutchinson and state Rep. Jehan Gordon-Booth want to shield local banks against.

The sponsors of those two bills believe that just as the states have taken the lead in seeing marijuana legalized, they too must play a leading role in ensuring that banking laws are reformed to accommodate those cannabis businesses. The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) and The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) wish that such laws were passed much earlier so that legitimate cannabis businesses stop being treated like second-class entities.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

A bipartisan bill introduced in Congress last week (March 12) seeks to shield federal employees from being fired once they test positive for marijuana.

The bill, introduced by Reps. Don Young (R-AK) and Charlie Crist (D-FL), is intended to clarify that federal workers who consume cannabis in states where it is legal cannot be held liable under federal law for testing positive for the substance.

Currently, federal employees can be summarily fired or denied a job if they test positive for THC. This blanket action happens regardless of state law.

Crist explains that the existing policy and law disproportionately impacts veterans because many of them have taken to medical marijuana in order to deal with various issues, such as PTSD and chronic pain. For such veterans, medical cannabis provides an alternative to harmful and addictive opioids.

Crist also notes that one third of the federal workforce is made up of veterans, and the law is unfair to this section of federal employees because they didn’t ask to suffer from the conditions that led them to use medical marijuana.

The bill wants to address the legal conflict that often puts veterans and other employees (or prospective employees) in a difficult position in which they have to choose between using medical cannabis and retaining their employment. No one should be forced to make that choice if medical cannabis is legal in the state where the person lives or works.

However, the bill doesn’t try to stop employers from conducting drugs tests and acting on the results if a person is suspected to have been intoxicated while on the job. Federal employees who require top secret clearance are also exempted from the protections outlined in this bill.

The previous version of this bill didn’t provide protections to individuals who used cannabis in conformity with the policies of Indian tribes. This present version includes such people.

The present bill also used the term “personnel action” when describing the protections offered. The inclusion of the term “personnel action” was intended to clarify that the bill should not be interpreted to mean that federal employees were protected from criminal action resulting from their use of marijuana.

It is hoped that this bill will be enacted so that talented individuals aren’t denied federal employment opportunities. Sugarmade, Inc. (OTCQB: SGMD) and Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) wish the sponsors of the bill success since their intention of protecting veterans and other federal employees is a good cause.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Following the passing of the 2018 Farm Bill, CBD sales have continued their massive growth in the United States and beyond.

• Cannabidiol (CBD), a chemical found in cannabis, has seen a huge growth in sales over the past few years.
• CBD can be derived from hemp, and the passing of a new farm bill in the States makes this form of cultivation legal at a federal level.
• This forms part of wider growth in the cannabis market, as companies expand their operations in North America and even beyond.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) is among the companies benefiting from this market, with an increase of more than 300 percent in online sales for its CBD products last year. Some companies are specializing in particular niches, such as The Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD) with its focus on sustainable organic plants. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) is making moves into Europe, with cannabis oil sales in Germany and investment in a Portuguese grower. Green Growth Brands Inc. (OTCQB: GGBXF) (CSE: GGB) is launching new products and opening its own shops across the United States. And HEXO Corp. (NYSE: HEXO) (TSX: HEXO), which recently expanded from medical cannabis into…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

CannabisNewsWire Editorial Coverage: The growth of the hemp sector is having a beneficial effect for both hemp companies and hydroponic suppliers.

• The growth of hemp more than doubled in the United States last year
• More companies are moving to produce hemp, causing a surge in demand for cultivation and hydroponic supplies
• Shortages are particularly acute relative to the hemp micropropagation and hemp cloning supplies as the spring planting season looms

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) via its pending acquisitions is poised to accelerate its growth rate as a result of this hemp cultivation boom, along with other leading companies. Tilray Inc. (NASDAQ: TLRY) has been expanding through the acquisition of other companies and a move into Europe, with a successful harvest in Portugal. Canopy Growth Corp. (NYSE: CGC) (TSX: WEED) is using outside investment to expand from Canada to New York and to develop CBD-infused drinks. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has also seen substantial outside investment thanks to growing faith in hemp. Aphria Inc. (NYSE: APHA) (TSX: APHA) has even faced a hostile takeover attempt as some companies look for…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

When Minnesota legalized medical cannabis in 2014, a task force was established to evaluate the medical cannabis program and report back to the state. However, numerous complaints about the operation and effectiveness of this task force have arisen.

Representatives of patients, law enforcement agencies, the medical community, lawmakers and other stakeholders make up this task force. The task force is mandated to scrutinize patient access to the medical marijuana program, the affordability of the products and any other issue connected to medical cannabis.

However, the task force appears to have been doomed right from its very inception. For example, the law establishing this entity wasn’t very clear on the exact duties of the task force.

Consequently, some of its members thought that the task force would assess the conditions that people wanted to be added to the list of qualifying conditions and then make recommendations on the same while other members didn’t think the task force had that authority.

Additionally, the composition of the task force appears not to be conducive for the group to do its work. This is because the task force has members who have divergent views about the appropriateness of having a medical cannabis program in the state.

Such divergent views of the proponents and opponents of the medical marijuana program create a lot of tension during meetings, so it is hard for the members to agree on anything.

As if the issues above weren’t bad enough, the task force rarely meets. For example, the last meeting they held was in 2017. It is nearly two years since they held a meeting!

Even the meetings that have been convened haven’t been well attended. Denis Flaherty, the ED of the Minnesota Police and Peace Officers Association, revealed as much when he decided to resign his membership on the task force.

He said that being on the task force was “a waste of my time” due to the poor attendance and the lack of impact that the meetings were having.

Because of the lack of impact by the task force, medical marijuana remains very expensive (and many patients have resorted to the black market).

These complaints about the task force haven’t gone unnoticed by the powers that be in the state. For example, Rep. Heather Edelson has drafted a bill to clarify how often the task force should meet, and the specific issues they should consider during that annual meeting.

Gov. Tim Walz also acknowledged that there were frustrations with the task force. He revealed that he was considering recreating the group into a new one that will consider the legalization of recreational marijuana in addition to assessing the medical cannabis program.

It seems there is all round consensus that something needs to be done to make the task force more useful. Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) call on all the concerned authorities to revisit the task force so that medical marijuana patients aren’t exposed to preventable inconveniences.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Two committees in the New Jersey Senate and Assembly voted on a bill to legalize recreational marijuana today (March 18). If the bill passed in both committees, then the entire House could vote on the matter as soon as March 25.

Stephen Sweeney, the Senate President, revealed that the members had received copies of the bill on Thursday last week and that the Democrats in the House have started talking to Republicans in order to get some of them to vote for the bill.

The support of some Republicans was crucial, because a number of prominent Democrats in the House were likely to vote against the bill. In order to pass, at least 21 Senators needed to vote for the bill.

The current bill is a modified form of the original version. The tax system suggested in the original version was changed so that marijuana could be taxed by weight instead of imposing an excise tax on every sale made.

The modified bill also has a provision to expunge the criminal record of individuals who were arrested or convicted for marijuana distribution. This didn’t exist in the previous version of the marijuana legalization bill.

It is this modified bill that the Senate Judiciary committee considered and voted on at 2:00 p.m. today, while the Appropriations Committee of the Assembly sat at noon today.

Marijuana proponents say they aren’t inventing marijuana. Rather, it is present in the different communities, and the social injustices committed during the so-called war on drugs also exist.

Passing the legalization bill would regulate the cannabis industry and get it out of the hands of criminal gangs. The state would earn taxes from the industry and thousands of jobs would be created. All this isn’t bad, the advocates say.

Another bill that was voted on today aims at increasing the quantity of medical cannabis that a patient can buy in the state. The bill also set in motion steps to end the imposition of excise tax on medical cannabis by 2024, in addition to legalizing marijuana edibles.

A third bill aims at making it easier for New Jersey to expunge marijuana charges from the criminal records of those who qualify under the law. For example, the mandatory time that must elapse before the charges are expunged will be reduced under this law.

This week may potentially be a turning point as far as marijuana is concerned in New Jersey. SinglePoint, Inc. (OTCQB: SING) and Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) called for an objective assessment of the bills before voting took place. Such a sober approach will ensure that the best decisions are made on behalf of the people of New Jersey.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

If the attendance record of last year’s event is any guide, more than 1,000 cannabis cultivators, consultants, capital market pros, retailers and R&D professionals will assemble for the next-gen Cannabis Conference 2019 hosted by Cannabis Business Times and Cannabis Dispensary.

The three-day event will be held on April 1-3, 2019, at the Westgate Las Vegas Resort and Casino in…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: CBD-infused beverages look set to hit the market in a big way in 2019.

• Cannabidiol (CBD) is widely used in health and wellness products after spectacular growth in recent years.
• Several companies are lining up to launch CBD drinks following legal changes in the United States and Canada.
• Integrating these new offerings into wider product lines is accelerating CBD’s race for mainstream attention.

Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) is one of the first to launch, with a CBD coffee coming in May and a CBD water in the works. The Alkaline Water Company Inc. (NASDAQ: WTER) (TSX.V: WTER), which is constantly growing its U.S. distribution network, plans to add a CBD bottled water to its range. The New Age Beverages Corporation (NASDAQ: NBEV) is adding CBD to its line of organic cold coffees and teas. Heineken (OTCQX: HEINY) has also entered the market by developing a cannabis-infused sparkling water through Lagunitas, its U.S. craft brewer. And the biggest investment in the overall cannabis space has come from Constellation Brands Inc. (NYSE: STZ), which has invested…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Last Saturday (March 9) saw history being made in the UK as the first specialist medical cannabis clinic opened in Manchester. The clinic is called The Beeches Consulting Center.

The opening of this clinic has been widely welcomed by patients and clinicians in the UK. This cannabis clinic is owned by European Cannabis Holdings (ECH), a group of companies that plans to open many more such clinics across the UK.

The clinic will be headed by two respected professionals in the medical field. These are an independent pain specialist, Dr. David McDowell, and the second is a consultant neurologist, Professor Mike Barnes.

Dr. McDowell also holds the distinction of being the first specialist to issue a medical cannabis prescription in the UK when the British government enacted a law that made it possible for patients to access medical cannabis starting from December 1. 2018.

Forzana Nazir is one of the first patients that Dr. McDowell issued a medical cannabis prescription to. She is eternally grateful for this because she has been able to transition from taking 13 different medications for her genetic disorder to just three prescription medications ever since she started taking medical marijuana.

Nazir suffers from Ehlers Danlos Syndrome that made her nearly bedridden on a permanent basis due to the severe pain, vomiting and nausea. She credits medical marijuana for significantly improving her quality of life and also for weaning her off many prescription opioids.

The opportunities offered by this new clinic have huge significance given the difficulties that patients have been experiencing if they want to access medical cannabis through the NHS (National Health Service).

Patients are required to establish exceptional clinical circumstances, exhaust all the current treatment options available in the UK, get approval from an NHS Trust Medical Director and then get a medical specialist who is willing to accept liability for their medical cannabis treatment. Only then can a patient receive medical marijuana from the NHS. Any wonder that only four patients have so far accessed the NHS medical marijuana?

The clinic in Manchester, and others that will be opened, will offer an alternative to the complicated bureaucracy associated with getting medical marijuana through the NHS. For now, the clinic will treat chronic pain (due to arthritis, spasticity, fibromyalgia, etc.), psychiatric conditions (anxiety, depression, PTSD, etc.) and neurological conditions, such as Parkinson’s disease, Alzheimer’s, multiple sclerosis and epilepsy.

Net Element, Inc. (NASDAQ: NETE) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) congratulate ECH upon that major milestone of opening the first specialized medical marijuana clinic in the UK. That is a major investment which should open the eyes of other businesses to the massive opportunities that exist in the cannabis industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Last month, we reported that there was a run on CBD drinks and other CBD products in the UK after the EU declared that CBD and other cannabis or hemp extracts were novel foods that could only be allowed on the market after receiving regulatory approval. Cannabis industry players in the UK aren’t taking that ban lying down. Their association has instructed a team of lawyers to head to Brussels in order to try and overturn that ruling.

While the EU law, (EU) 2015/2283, isn’t binding on the member states, many countries use the guidance provided by the EU to draft their own domestic laws and regulations. Actually, many EU countries promptly act on those recommendations then ask questions later.

For example, Austria immediately banned CBD and all food products containing it as soon as the EU made its ruling on the products.

Cannabinoids were categorized as novel foods by the EU since industry players “failed to prove” that those products had a history of being consumed in the EU prior to 1997 when the European Food Safety Authority (EFSA) was established.

Mackrell Turner Garrett, a London-based law firm, together with a leading trading standards and food attorney in the UK, have been sent to Brussels to meet EFSA officials in order to argue the case of the CBD industry in the UK.

The lawyers are acting on behalf of the Cannabis Trade Association UK and they will try to convince EFSA at the EU headquarters that since hempseed and hempseed extracts have already been approved, then they don’t belong in the category of the novel foods that should be banned.

This will be a tough fight to complete because the EU has a history of being cautious regarding any major global developments with origins in North America. This pushback has particularly been strong ever since the financial meltdown of 2008.

But the team from London is unfazed and wants to argue the case of its members. CBD has grown so rapidly that in just three years, the CTA (Cannabis Trade Association) has grown to more than 700 members.

Additionally, the CBD industry contributes approximately $130 million to the British economy each year. It remains to be seen whether the arguments presented by the lawyers will change the minds of the regulators in Brussels. Medical Cannabis Payment Solutions (OTC: REFG), MustGrow Biologics Corp. and other people who see investment opportunities hope that Brussels changes its stand so that the growth of the industry isn’t torpedoed at this point.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
As the cannabis market grows, companies are seizing the opportunity to make strategic investments in the sector and establish a foothold in the promising space.

• Cannabis and related products are legal in an ever-increasing number of jurisdictions.
• Businesses have responded with an increasingly diverse range of products.
• Companies making the smartest investments, such as carefully selected mergers and acquisitions, are in the best position to profit from this while minimizing risks.

SinglePoint Inc. (OTCQB: SING) (SING Profile) has invested in a number of other cannabis companies to grow its portfolio and leverage its position in the market. Marijuana Company of America Inc. (OTCQB: MCOA) (MCOA Profile), with its hemp-oriented business, is expecting a surge in profits following the crop’s federal legalization in the United States in December. Medical Marijuana Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, has seen record sales. PotNetwork Holdings Inc. (OTC: POTN) is reaching out to new customers with a CBD-infused slushy machine. And American Premium Water Corp. (OTC: HIPH) is also pushing CBD into the soft drinks market with its infused water.

To view the full editorial, visit http://cnw.fm/80Tmn

To hear the CannabisNewsAudio version, visit: http://cnw.fm/dZbK7

About SinglePoint, Inc.

SinglePoint, Inc. is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing products and services to the cannabis industry. For more information, visit the company’s website at www.SinglePoint.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

You would expect that with more than 17 years of existence in Canada, medical cannabis should have already led to policy changes in various aspects of life in the country. However, if the claims of injured workers are anything to go by, workers’ compensation guidelines have been slow in changing to accommodate this form of treatment. Now matters are beginning to shift as the discussion below shows.

More Workers Winning in Tribunals

Mellissa Ellsworth is just one of 10 patients who have won hearings in Nova Scotia’s workers’ comp tribunal set up to assess whether the Workers’ Compensation Board should cover the cost of medical marijuana. It took her five years to get this approval.

Alberta’s board has so far also accepted to cover the medical marijuana costs of 10 workers who were injured on the job. New Brunswick shines in this regard because it has so far approved 71 patients’ applications for medical cannabis costs coverage under workers’ comp policies.

It is saddening that patients have to endure years of pain as their applications slowly make their way through the red tape of the Workers’ Compensation Boards in the different provinces and territories. For example, the neurological pain experienced by Melissa Ellsworth led her to take a total of 26 pills on a daily basis just to function as a normal human. She now takes only cannabis and enjoys a better quality of life.

The good news amidst all this is that for each patient who gets approval, more are encouraged to table their requests before the different boards. Eventually, medical cannabis will become a normal form of treatment and no patient will have to go through what the pioneers like Melissa Ellsworth had to endure to get approval.

Doctors’ Prescriptions Rarely Considered

You would think that the different Workers’ Compensation Boards would attach some weight to the recommendations provided by the primary healthcare providers of the patients who apply for coverage.

However, only Quebec recognizes and acts upon those recommendations. Other boards convene their own medical team sittings to assess the eligibility of a patient for medical cannabis. Why should this happen when Health Canada screens patients before giving them a medical cannabis card?

Caps on Daily Cannabis Consumption

Nearly all provinces and territories that are even willing to consider paying for medical cannabis for injured workers impose a three gram cap on how much medical cannabis a patient can claim coverage for each day.

While there may be valid reasons for this cap, it would be reasonable for these boards to acknowledge that different patients have different needs, so mechanisms should be available for those who need more to be covered without major hassles. Even Health Canada allows patients to grow hundreds of cannabis plants if they need a lot on a daily basis for their treatment. But, workers’ comp boards still insist on three grams a day!

But, There’s Progress…

Amidst this huge cloud hovering over injured workers in Canada, winds of change are slowly picking up. Last year, New Brunswick set the stage by passing medical cannabis guidelines. Prince Edward Island followed suit, and now Nova Scotia is drafting its own set of guidelines.

While all this is happening in Canada, one wonders what the situation is here in the U.S. With most marijuana businesses still struggling to access banking services, it is hard to picture what patients may be going through if they wish to have their medical cannabis costs covered by workers’ comp insurance. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America (OTCQB: MCOA) decry the slow rate at which workers’ compensation is evolving to accommodate medical cannabis. This isn’t only denying patients a viable treatment option, but it is also limiting the investment opportunities that would boost the economy.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The cannabis bullet train doesn’t seem to be showing any signs of slowing down in Missouri ever since voters overwhelmingly passed a ballot measure in the recent midterms to legalize medical marijuana in the state. Now more than 300 businesses are due to be licensed to participate in the medical cannabis industry once it is commercialized.

This announcement was made by Lyndall Fraker, the Missouri Medical Marijuana Program Director, while speaking at a medical marijuana conference in St. Louis on Monday (March 11). He added that if those 300 licenses weren’t enough, then the state wouldn’t hesitate to grant more to the businesses that wish to serve Missouri patients in different capacities.

Already, more than 450 applications have been received from entities that would like to cultivate, manufacture, dispense or test medical marijuana and its products in the state. It is from this pool that the state will select the first 300 businesses to be licensed.

For now, the regulator has set the minimum number of players that will operate in the different segments of the medical marijuana industry. These include at least 192 dispensaries, two marijuana testing facilities, 85 manufacturing facilities and 60 marijuana cultivation facilities.

When added up, those figures exceed the 300 licenses that will be awarded initially, so you can see that the state already has plans for an extensive and robust medical cannabis industry.

You may be wondering, won’t 300 businesses be too many for an industry that is just being set up? This concern may be legitimate, but if anything is to be learnt from the Canadian recreational cannabis industry, it is risky to allow only a few players in the industry.

The cannabis shortages in Canada can largely be explained by the country’s failure to license enough businesses to participate in the different aspects of the cannabis value chain. The resulting mess will possibly take years to fix. Missouri may therefore be onto something when they start off with hundreds of licensed businesses.

Besides, not all of those 300 businesses will start operations at the same time. And when they do start, not all of them will be successful. Others will close shop while more will merge with other businesses.

It is therefore a good thing that the state intends to give all those businesses a shot and then their fate will be squarely in their hands once they get hold of a license. Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), Green Hygienics Holdings Inc. (OTCQB: GRYN) and all who wish to invest in the medical cannabis industry welcome the steps being taken by the Missouri Medical Marijuana Program to do things right from the get-go.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

• Keynoters include Giadha Aguirre de Carcer, founder and CEO of New Frontier Data; and Cam Battley, CCO of Aurora Cannabis
• Benzinga conference features company presentations, panels on cannabis markets and networking opportunities
• Tickets sold out for prior conferences in the series

Benzinga Cannabis Capital Conference is expected to attract both institutional and retail investors, as well as cannabis executives, with an agenda that’s jam-packed full of presentations, panels and networking opportunities. The conference will be held on April 17-18 in Toronto at the Fairmont Royal York. Prior conferences in the series – in Toronto in 2018 and Miami in 2019 – sold out (http://cnw.fm/0T3gJ).

Reserve your ticket now at http://cnw.fm/7hlO3.

On the first day (April 17), hundreds of cannabis executives and investors will hear engaging panels from industry leaders. Topics discussed are set to include post-legalization Canada and analysis of volatile and targeted markets, such as…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: As the cannabis industry expands, companies are eyeing strategic opportunities in the sector designed to help them establish a foothold in the promising space.

• Cannabis and related products are legal in Canada and an increasing number of states.
• Businesses have responded with a growing range of diverse products.
• Companies making the smartest investments, including carefully selected mergers and acquisitions, are in the best position to profit.

SinglePoint Inc. (OTCQB: SING) (SING Profile) has invested in a number of other cannabis companies to grow its portfolio and leverage its position in the market. Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) just signed of letter of intent with Malta Enterprises, the economic development agency of Malta. MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) recently wrapped up its previously announced acquisition of Kannaboost Technology Inc. and CSI Solutions LLC, two vertically integrated Arizona-based operations. Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) reported more than 10 times growth in harvested hemp compared to its 2017 grow season. And Curaleaf Holdings Inc. (OTCQX: CURLF) (CSE: CURA) has signed a definitive agreement to acquire…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Voters approved a ballot measure in 2008 to legalize medical cannabis in Michigan and since then, the list of the qualifying conditions has been expanding slowly. Cerebral palsy is the latest condition to be added onto that list which has just over two dozen health conditions.

LARA (the Department of Licensing and Regulatory Affairs) made the announcement after its sitting to consider the different conditions which had been proposed for inclusion on the list of medical marijuana qualifying conditions. LARA rejected requests to include Chronic Aggressive Behavior among the conditions that can be treated or managed using medical marijuana.

Cerebral palsy, a neurological disorder, develops when the brain of a child gets injured during its developmental stage. Some of the symptoms that can result from this condition are lack of motor function and control. There is evidence that marijuana can help to reduce the spastic movements or the seizures experienced by people suffering from cerebral palsy.

According to the statistics of the United Cerebral Palsy Foundation, about 764,000 people are affected by this disorder in the U.S. Most of those individuals (500,000) are kids that are less than 18 years of age.

It is therefore a big help that cerebral palsy has been added to the list of qualifying conditions in Michigan since conventional medicine offers little help to people suffering from this condition.

It is hoped that more people will now be able to get medical cannabis cards from the state. Currently, 294,000 people are registered and have medical marijuana cards in Michigan.

Accessing the medical marijuana program doesn’t have any age restriction, and many kids with various conditions, such as seizures, are cardholders in the state. The only extra requirements for kids is that a minimum of two doctors should recommend them to start using medical cannabis and the parent or guardian of that minor has to give consent for the child to start taking medical marijuana.

Last year, Michigan voters approved a ballot measure to legalize recreational cannabis. Adult-use cannabis will only be available to those who are at least 21 years old. Plans are underway to set up a regulatory system for the recreational sector, but the medical cannabis program will remain intact.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) and Generation Alpha, Inc. (OTCQB: GNAL) applaud the progressive approach taken by LARA which will allow patients and investors in Michigan to benefit from cannabis as the industry evolves.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Senator Anthony Delcollo has introduced a bill in the state senate to change the law so that doctors will be free to decide which patient would be helped by medical marijuana instead of first checking whether that patient has a condition listed in the medical marijuana law.

Under the current law which was passed in 2011, patients can only qualify to get onto the medical marijuana program if they have one of the “debilitating conditions” such as terminal illnesses and cancer.

Delcollo argues that doctors undergo extensive training and have a lot of experience in the field. These professionals should be given the liberty to decide what is in the best interest of their patients, he says.

Senate Bill 24 is therefore intended to free doctors to use their discretion in determining whether medical cannabis will provide “palliative or therapeutic benefit” to patients.

The senator argues that this wouldn’t be a new thing since doctors are already exercising their professional discretion to determine which pharmaceuticals on the market are most likely to be beneficial to their patients.

Medical cannabis advocates concur and say that the proposed change is long overdue. They add that it should have been part of the first law that legalized medical marijuana in the state in 2011.

The bill is also intended to ease the restrictions on the kinds of medical specialists that are authorized to recommend the use of medical cannabis by patients who are younger than 18. However, the change would not alter the current provision stating that patients who are less than 18 can only use cannabis oil and not any other form of medical marijuana.

Senate Bill 24 enjoys bipartisan sponsorship and support, so it is hoped that the lawmakers will debate it thoroughly and give it the nod.

If it passes, Delaware will join Oklahoma and Maine as the only states that give doctors such leeway in deciding who can or cannot be treated using medical marijuana.

It hasn’t been an easy journey for Delaware to get to this point. It should be recalled that there were endless delays in opening the compassion centers where patients could access medical cannabis. To date, only four such centers are operational in the state.

More recently, there were plans to legalize recreational marijuana legislatively. More than a year was taken to debate the bill and when a vote was called, the bill was defeated by just four votes in June last year. No other recreational marijuana bill has yet been tabled during this legislative session.

Be that as it may, Global Payout, Inc. (OTC: GOHE), Golden Developing Solutions, Inc. (OTC: DVLP) and the entire investment community are hoping that this time round, appropriate legislation improving the medical cannabis environment is passed so that all interested parties, such as patients, can benefit.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Multifaceted financial news and publishing company CannabisNewsWire (“CNW”) this morning announced that it will once again serve as the official newswire and media sponsor for the Cannabis Capital Conference to be held at the Fairmont Royal York in Toronto, Ontario from April 17 through April 18, 2019. Hosted by leading financial media outlet Benzinga, the conference attracts a wide range of cannabis entrepreneurs and investors throughout North America and offers unparalleled networking opportunities and a full itinerary of presentations, panel discussions, lightning rounds and keynote addresses centered around the dynamic industry. “The Benzinga Cannabis Capital Conference is one of the most auspicious gatherings in the cannabis space, and CannabisNewsWire is excited to be partnering with its organizers once again,” CNW Communications Director Jonathan Keim said in the news release. “This premier conference attracts North America’s leading cannabis innovators, investors and entrepreneurs. Attending and networking among these great men and women, while working to promote this industry and its key players, is a true privilege.”

To view the full press release, visit http://cnw.fm/QdRJ6

About Benzinga

Benzinga is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s top traders. Benzinga provides timely, actionable ideas that help users navigate even the most uncertain and volatile markets – in real-time with an unmatched caliber. From breakouts to unusual volume, analyst ratings, futures and options, Benzinga is the leading full-service, one-stop shop for investors of all stripes and styles. For more information, visit www.Benzinga.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The Georgia House of Representatives voted last week (March 5) and passed a bill intended to regulate the manufacture and sale of medical marijuana oil. This bill now goes to the state senate for consideration before it becomes law.

The existing regulations in Georgia don’t allow the cultivation, manufacture or sale of cannabis oil, and this has left patients using medical marijuana in the state with no source of cannabis oil even if the laws allow the use of that oil as long as its THC content doesn’t exceed 5 percent.

House Bill 324 is geared at changing that so that patients who enroll on the medical cannabis program can access medical cannabis oil.

Once the bill is enacted into law, the 8,400 patients who have so far registered in the medical cannabis program of the state will be able to buy cannabis oil from one of the 60 medical marijuana dispensaries in the state.

Allan Powell, the Republican chair of the committee that initially considered the bill before sending it to the entire House for a vote, said that he was happy that a legal avenue was being created for qualifying patients to access marijuana oil.

He added that it was hypocritical to pass a law stipulating what kind of cannabis oil patients should use yet no mechanism was put in place to make it possible for patients to access that oil.

House Bill 324 sets the bar high for companies that would like to participate in the medical cannabis industry of the state. For example, large companies will have to pay $150,000 for a license while smaller companies will have to fork out $37,000. It will cost $30,000 to get a license to operate a medical cannabis retail business.

Renewing those licenses will not be any easier either. The fees for this range between $10,000 and $50,000. The businesses had better attract a large volume of sales if they are to thrive despite these high license acquisition and renewal fees.

Meanwhile, the bill still has opposition outside the chambers of the lawmakers. For example, the Georgia Sheriffs’ Association led by Terry Norris has described the bill as something that will take the state down a dangerous and treacherous path that may end into kids using marijuana while adults will eventually switch from cannabis to more dangerous drugs.

Such scaremongering isn’t new, but it may amount to nothing since even the Governor has promised to sign the law once it is passed by the senate. Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and ChineseInvestors.com (OTCQB: CIIX) hope that the legislation will be passed and implemented expeditiously so that patients and investors don’t have to wait any longer than is necessary for them to access medical cannabis oil or the opportunities the industry offers.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

First, the World Health Organization (“WHO”) delayed and postponed the release of its recommendations after an expert committee studied proposals for the reclassification of cannabis in international treaties. Now, yet another delay has hit that activity and the UN has announced that the March sitting of the UN Commission on Narcotic Drugs, and the one in December this year, will not have marijuana reclassification on its agenda.

The recommendations of WHO had initially been scheduled to be voted on in December last year, but this was inexplicably postponed.

Some of the 53 members of the Narcotic Drugs Commission reportedly claimed that they needed additional time to study the recommendations made by the World Health Organization before they can decide how to vote when a vote is called.

Other members, such as Uruguay and Norway, were disappointed that no timeline was set for when the recommendations will be considered and voted upon. There are fears that the matter may be put on the backburner for an indefinite amount of time, for political reasons.

The recommendations were widely seen as a way for many countries to be free to embark on medical cannabis research and legalization, with others taking it a step further and decriminalizing adult-use marijuana.

The WHO had recommended that whole-plant marijuana and its resin should be removed from the strictest category (Category 4) of the 1961 International Drug Convention and placed in a less restrictive category.

To put this into perspective, the U.S. system of categorizing controlled substances is different from that of the UN. For example, in the U.S., Schedule 1 is reserved for the substances that deserve the strictest controls and the restrictions reduce as the schedule number gets bigger. This is unlike the UN where the smaller numbers have fewer restrictions while the bigger numbers, such as Category 4, have more stringent restrictions.

Meanwhile, as the UN is still playing hide and seek regarding its position on the calls for marijuana rescheduling, Europe is taking a different path. The EU Parliament approved a resolution calling on member states to avail support and funding for medical cannabis research. While the decision isn’t binding, it could pave the way for widespread research and legal reforms in EU member countries. This will leave the U.S. further behind in the rapidly evolving cannabis industry.

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) and Earth Science Tech, Inc. (OTCQB: ETST) call on the UN to stop dragging its feet and make the decision for which the world has been waiting.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

• Event slated to include a business conference, industry awards, an industry expo and a public expo
• Topics include growing and cultivation, cannabis science, health and wellness, and policy and regulations
• O’Cannabiz Conference & Expo expected to feature more than 120 world-class speakers, 7,000 attendees and 250 exhibitors

O’Cannabiz Conference & Expo will bring together cannabis professionals and industry experts from throughout Canada and around the world on April 25–27 at the International Centre in Toronto. Celebrity speakers will include Montel Williams, Ricki Lake and Henry Rollins. Learn more at www.OCannabiz.com.

Reserve tickets now and register at http://cnw.fm/685Fn.

O’Cannabiz will offer a diverse mix of business conferences, industry awards and industry and public expos. The event is designed to gather together global and Canadian professionals to teach participants about growing cannabis, managing businesses and becoming knowledgeable regarding policy and…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: As the cannabis market grows, companies are seizing the opportunity to make strategic investments in the sector and establish a foothold in the promising space.

• Cannabis and related products are legal in an ever-increasing number of jurisdictions.
• Businesses have responded with an increasingly diverse range of products.
• Companies making the smartest investments, such as carefully selected mergers and acquisitions, are in the best position to profit from this while minimizing risks.

SinglePoint Inc. (OTCQB: SING) (SING Profile) has invested in a number of other cannabis companies to grow its portfolio and leverage its position in the market. Marijuana Company of America Inc. (OTCQB: MCOA) (MCOA Profile), with its hemp-oriented business, is expecting a surge in profits following the crop’s federal legalization in the United States in December. Medical Marijuana Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, has seen record sales. PotNetwork Holdings Inc. (OTC: POTN) is reaching out to new customers with a CBD-infused slushy machine. And American Premium Water Corp. (OTC: HIPH) is also pushing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

From the reports in the media and what people discuss, one is led to believe that CBD (cannabidiol) contains all the medicinal benefits in the cannabis plant while THC (tetrahydrocannabinol) symptomizes everything that is bad about cannabis since it is psychoactive. However, the findings of a recent study may turn this popular belief on its head.

According to a study whose findings appeared in the Scientific Reports Journal, THC seems to have a higher link with the relief of disease symptoms when compared to CBD.

The researchers from the University of New Mexico studied the data provided by medical cannabis users in the U.S. regarding various aspects of the medical cannabis that they consumed. The ReLeaf app allows patients to indicate various things, such as what they are suffering from, what marijuana strains they are consuming, how they are consuming that marijuana and what effects they notice after consuming medical cannabis.

The researchers looked at the data and found that the patients who used marijuana strains that had higher levels of THC when compared to the CBD content reported superior symptom relief unlike those patients whose medical marijuana had low levels of THC and higher levels of CBD.

Sarah See Stith, one of the co-authors of the research commented that their study was important in light of the fact that not enough information is given to patients when they want to try medical cannabis for their conditions.

Stith pointed out that almost all patients get a recommendation from a doctor and are on their own in terms of selecting the products to use. Some of those patients rely on their prior experience when they used to consume recreational marijuana. Others talk to family and friends while some go to the internet to educate themselves about medical cannabis. The staff at medical cannabis dispensaries are often poorly trained, so they cannot be relied upon to give dependable advice on the appropriate medical cannabis products for patients.

Stith thinks that their research findings can help to initiate a discussion and further research into how cannabis works to treat or provide symptomatic relief.

This research is also important because it comes at a time when the U.S., the UN and other international bodies are on the verge of deciding whether to reschedule cannabis or leave it in the most restrictive categories of the national/international treaties controlling narcotic substances.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) welcome this research and hope that those findings will be considered by those who formulate cannabis policies and regulations in Washington.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

According to recent media reports, the National Football League (NFL) may be considering changing its substance abuse rules with regard to marijuana. Analysts expect that the NFL may try to use any changes that it makes to its marijuana rules as a negotiating chip during its talks with the NFL players’ union.

A former offensive linesman, Kyle Turley, has also revealed that the NFL is studying the possibility of using cannabis as an alternative to pain killers. Research is being done by the NFL in this regard.

Kyle Turley owns a company that makes CBD supplements for athletes, so he can be expected to have an ear on the ground regarding the developments in the league, especially those developments that may impact his business either positively or adversely.

Roger Goodell, the NFL Commissioner, admitted in January that he had talked to some players’ representatives about marijuana. He added that the medical advisers of the league constantly look at the new research and the available data regarding the effects of cannabis on the players and advise accordingly.

In the past, Goodell was unequivocal in his opposition to the consumption of marijuana in the league. For example, in 2017, the Commissioner told ESPN that ingesting smoke (cannabis) couldn’t in any way be good for an NFL player.

However, recent times have seen a decline in the vigor that the league deploys to enforce its policy on marijuana even if some players have been suspended for testing positive for the substance. Those players were given a chance to return to the league yet previously one would be out for good.

While the news that the NFL may be thinking about changing its policy on cannabis may be good, industry advocates are wondering what the Commissioner and his team have up their sleeves. For example, what kind of concessions do they want to squeeze out of the players’ union in return for altering the policy on cannabis?

What these advocates had expected were statements to the effect that the NFL regrets any past actions that may have driven players into opioid addiction yet cannabis would have saved them and kept them playing. This is exactly what is happening in the states that are legalizing recreational cannabis. There is an admission that the war on drugs meted out untold suffering on sections of the population, and that legalization wants to put that past behind.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and other industry players like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) hope that the NFL changes its cannabis policy for the right reasons, instead of using it as a tool to manipulate the players.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Individuals hoping to gain exposure to the movement of the markets have two primary options: spend a lot of time and effort researching public companies, or put faith into a fund. A solid investment strategy is key to keeping pace with inflation and reaching your financial goals, but the significant risk and volatility that can come with investing in a small group of companies is a real turn-off for most part-time investors.

Increasingly, novices and seasoned traders alike are turning to mutual funds for their stability and ease of use. According to data from the Investment Company Institute, mutual funds were the most common type of investment company owned in 2018, with 44.8 percent of U.S. households owning shares of mutual funds or similar U.S.-registered investment companies – including exchange-traded funds (ETFs), closed-end funds and unit investment trusts. As Matthew P. Fink notes in The Rise of Mutual Funds: An Insider’s View, “Today U.S. mutual funds are…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

The House Judiciary Committee in Kentucky voted on Wednesday (March 6) to pass a bill that would legalize medical cannabis in the state. The bill will now be sent to the Rules Committee of the Assembly.

House Bill 136 was co-sponsored by 43 members out of the 100 members in the entire lawmaking chamber. This bill intends to create a Department for Alcoholic Beverage and Cannabis Control. This agency will then design a medical cannabis program for the state.

The agency will also be responsible for giving medical marijuana licences to patients who meet the criteria for such a licence. Healthcare providers, processors, cultivators and dispensaries will also be regulated by this agency.

16 legislators on the House Judiciary Committee voted in favor of the bill while one lawmaker voted against it.

Opinion polls in the state show that 80 percent of all adults think that it is okay to allow patients to have the option of using medical cannabis if their doctors recommend it. Governor Matt Bevin has also expressed his support for medical marijuana.

Despite that support from the public and the Governor, attempts to legalize medical marijuana in the state still have major hurdles to overcome.

For example, Robert Stivers, the Senate President, has been vocal in opposing medical cannabis. He even went as far as comparing it to alcohol, saying that anyone who wanted to feel better or relax can take a glass or bourbon instead of consuming medical marijuana.

The Kentucky Medical Association is also adamant that it will only support medical cannabis legislation once the Food and Drug Administration (FDA) approves the use of medical marijuana.

The sponsors of this legalization bill are aware of this strong opposition and made a number of modifications to the bill in order to build some consensus around it.

For example, the original bill had provisions that would allow patients enrolled on the medical marijuana program to grow a maximum of six mature plants for their own use. This was dropped from the bill.

Another change that was made regarded the qualifying conditions for which a patient could use medical marijuana. Originally, the framers of the bill had wanted doctors to use their discretion to decide which patient would benefit from medical cannabis. The bill was amended to create a specific list of conditions for which patients could be treated using medical marijuana.

It is now up to the Rules Committee to decide whether House Bill 136 can now be put before the entire House for a vote. A decision must be made quickly, since this legislative session only has five more days before it ends.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) and TransCanna Holdings Inc. (CSE: TCAN) hope that the legislators make the best decision within the limited time left so that patients don’t have to wait longer for a treatment option that is already available in other states.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The U.S. Drug Enforcement Agency has published a notice asking interested parties to express interest in supplying it with equipment that can be used to determine whether a given cannabis plant is marijuana or federally legal hemp.

The notice that was issued last week indicated that such equipment was necessary since the 2018 Farm Bill made it federally legal to grow hemp but federal laws still consider marijuana to be an illegal substance/plant.

Note that hemp and marijuana are all cannabis plants, so one can only tell them apart by subjecting samples to tests for their THC content. U.S. federal law sets the maximum THC limit for hemp at 0.3 percent. Any cannabis plant with a higher THC content is marijuana, according to the current legal definition of those two plants.

The DEA wants to identify a supplier who has field kits that can help the agents of the law enforcement agency to tell those two plants apart.

The DEA is interested in procuring portable yet rugged equipment which will stand up to the harsh field conditions where rapid tests will be needed before a decision is taken to arrest possible offenders or impound a given consignment.

The agency also wants to buy the latest versions or models of such a product, and the number of units purchased will depend on how the equipment performs during its evaluation and what the needs of the agency will be at that time.

Why would the DEA need such equipment when the 2018 Farm Bill shifted matters of hemp to the Department of Agriculture?

It is true that the DEA falls under the Justice Department and they would ordinarily no longer be interested in matters to do with hemp. However, the DEA still has a mandate to enforce marijuana laws around the country, so the agency anticipates that it will encounter difficulties while trying to decide whether a given plant is hemp or marijuana. The test kits can help to clear the air when such a distinction is required.

The DEA has set a deadline of March 15 for interested companies to give it the information it needs to decide the details of the procurement process.

Meanwhile, pressure is mounting on the DEA to expedite the process of approving the companies that had applied to manufacture research-grade cannabis. Only Mississippi University is currently licensed to grow and process marijuana for research purposes, and its shortcomings have created the need for additional cultivators/manufacturers.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) and The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) applaud the foresight of the DEA in seeking testing equipment long before conflicts arise regarding what a given plant is during the law enforcement activities of the federal agency.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Northern Michigan University has admitted its first lot of students for its medicinal plant chemistry degree program. The students will have a chance to major in marijuana. So far, 300 students from across the country have enrolled for this pioneer program.

Analysts predict that the legal marijuana industry will create nearly half a million jobs by 2022. Recent research shows that more than 211,000 jobs have already been created, so the half a million jobs projected by 2022 could even be an underestimate.

Northern Michigan University wants to do its part by preparing lab analysts, quality assurance directors, cannabis dispensary operators, cannabis master cultivators, and so many other professional-level jobs.

Many universities across the country, including in states where cannabis is still illegal, have added some form of training in the cannabis industry to their offerings. For example, Ohio State University and Harvard University have started training students in cannabis policy and law.

The program offered by Northern Michigan University is the first to get students a detailed training on cannabis from seed to sale. However, the students will not be working with cannabis directly.

Rather, they will study other plants like hemp and St. John’s wort. They will extract medicinal ingredients from these plants and analyze them in a lab. This training can easily be applied to cannabis.

Additionally, as part of their training, the Northern Michigan University students enrolled on the program will do internships at medical marijuana dispensaries. By the time they graduate at the end of the four-year program, the students will be ready to excel as employees or entrepreneurs in the marijuana industry.

Brandon Canfield, a professor of chemistry at Northern Michigan University, revealed that the idea of the program came to him when he was attending a cannabis event and heard industry players lamenting that they aren’t getting the skilled employees that they need.

That conference led Canfield to propose that the university starts a major in therapeutic plant chemistry, and the course was born. Canfield is convinced that the graduates of the program will have an easy entry into the cannabis industry, with some of them even earning more than $70,000 a year right after graduation.

Grace DeNoya, one of the pioneer students on the program, agrees that the cannabis industry offers opportunities that no other industry may be offering at the moment. Getting in now as the industry is just taking off promises to be an exciting prospect with huge opportunities in the years to come.

Sugarmade, Inc. (OTCQB: SGMD) and Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) congratulate Northern Michigan University for being proactive and doing what they can to respond to the demand created by the cannabis industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Cannabis businesses and those affiliated to the industry have grown used to waking up and finding that their Facebook pages have been deleted or suspended due to being flagged for carrying unacceptable content (read marijuana). However, this may soon change if the internal discussions going on within the platform bear the desired fruit.

The social media platform is reportedly thinking about amending its rules so that Facebook users can promote the cannabis products that they sell. The existing policies don’t permit the sale of marijuana and other controlled substances on the platform.

If the changes are made, the sale of medical and recreational marijuana products in jurisdictions that have legalized cannabis will be permitted by the social media giant.

One of the big issues that Facebook has to work out is how the platform can decide whether a Facebook page belongs to an entity that is legal within the jurisdiction where it is based or operates.

Another dilemma for the platform is how it can stop access to minors if legal businesses or entities are allowed to sell cannabis or its products on the platform. This issue is compounded by the fact that different jurisdictions define their own minimum age at which someone can use weed legally.

Facebook also has to think about how a policy shift regarding marijuana will be perceived by the users of the platform in the different regions of the world. For example, some regions are strongly opposed to cannabis, and these areas may pushback against the platform for allowing companies to promote or sell marijuana on Facebook.

The task of thinking through all these issues has been assigned to an internal working group. This group will propose new rules for the platform and assess how practical it will be to implement those new rules.

If the policy shift is approved and implemented by the social media giant, it will mark a paradigm shift for the platform that had for long punished marijuana-related pages with blocked searches or outright bans.

Last year, Facebook lifted its “moratorium” on cannabis the day Canada legalized recreational weed. Cannabis is widely sold online within Canada, so Facebook may have had no choice if it didn’t want to risk losing a significant portion of its users in that country.

Previously, the social media platform didn’t stop companies and organizations from opening cannabis-related pages. However, the platform enforced its restrictions on marijuana so rigorously that government cannabis regulatory agencies and policy advocates often found themselves locked out.

It remains to be seen what form the changed policy will take given that the company insists that it will not allow paid ads and other methods of promoting cannabis content on the platform. SinglePoint, Inc. (OTCQB: SING) and Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) hope that Facebook wakes up to the changes in the world regarding cannabis and it stops putting unnecessary roadblocks to the industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The Benzinga Cannabis Capital Conference to be held at the stunning Fairmont Royal York hotel in Toronto on April 17 through April 18, 2019, will draw entrepreneurs and investors throughout the burgeoning cannabis industry. Premier financial media outlet Benzinga is hosting the event that will put cannabis industry information and ideas front-and-center for cannabis companies, policy makers, entrepreneurs and sector trailblazers. The conference agenda includes a full-slate of engaging panels, fireside chats, lightning round presentations, facilitated networking opportunities and leading industry keynote speakers. “Benzinga’s Cannabis Capital Conference brings an eclectic group of forward-thinking cannabis entrepreneurs and investors together in a setting that encourages deals, deepens knowledge, and enables progress for the cannabis sector,” Benzinga Vice President of Marketing Neal Hamilton said in a news release. “This conference series consistently attracts an outstanding array of investors, business owners and cannabis experts who are eager to learn, grow and succeed in this rapidly evolving marketplace.”

To view the full press release, visit http://cnw.fm/U2DMa

About Benzinga

Benzinga is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s top traders. Benzinga provides timely, actionable ideas that help users navigate even the most uncertain and volatile markets – in real-time with an unmatched caliber. From breakouts to unusual volume, analyst ratings, futures and options, Benzinga is the leading full-service, one-stop shop for investors of all stripes and styles. For more information, visit www.Benzinga.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

A committee of the Idaho State Assembly has approved funding so that the state police can buy the equipment needed to test whether a given plant is industrial hemp or marijuana. This plan comes after the police seized a semitrailer carrying what the arresting officer thought was marijuana while the driver and his employer insisted that the consignment contained hemp.

The owner of the cargo, Big Sky Scientific, tried to get a court order to compel the police to release the cargo since it was deteriorating rapidly as the police continues with its investigations. The company argued that it was now legal to grow hemp and transport it across state lines from the time President Trump signed the Farm Bill 2018 into law.

However, court declined to issue the court order since the state didn’t have a law prescribing how hemp could be grown. Furthermore, the court could not be certain that Big Sky Scientific had grown its “hemp” in accordance with the Farm Act 2018.

This case has captured headlines within and outside Idaho because it serves as an eye-opener of the kind of situations that law enforcement agencies are likely to face now that hemp is legal while marijuana remains illegal at the federal level.

This confusion is likely to arise because there is no difference in the physical characteristics of hemp and cannabis. It is therefore possible for someone to attempt to transport cannabis across state borders while passing it off as hemp. It is also likely that hemp cultivators will face a lot of inconveniences as they jump through hoops to prove that what they are cultivating or transporting isn’t marijuana.

The procurement of the testing equipment was initiated by some lawmakers (not the police department) who felt that it was unsustainable to keep sending samples to Kentucky each time a seizure or arrest was made by the police. The argument of the lawmakers makes sense, because Big Sky Scientific stands to lose its cargo due to the delays created by having to conduct tests outside the state yet the crop is highly perishable and cannot retain its quality while the legal issues are sorted out.

For now, the entire Assembly has to approve the $240,000 funding request before the spending proposals go to the state Senate for approval. Only then can the money be released to procure and install the testing equipment in the police testing facility. Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) call for the speedy procurement of the testing equipment so that additional problems can be avoided later on.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Because marijuana remains illegal at the federal level, it isn’t possible to get accurate statistics about the jobs available in the industry from federal agencies like the Bureau of Labor Statistics. However, Whitney Economics and Leafly.com decided to painstakingly gather the data from each state where cannabis is legal and their findings are eye-catching.

The data analysts discovered that so far, the legal cannabis industry has created 211,000 full-time jobs within the U.S. This shows that the industry is one to watch if the problem of unemployment is to be tackled.

The statistics collected show that out of the 211,000 full-time jobs created so far, 64,000 were filled in 2018 alone. Not bad for an industry that remains illegal at the federal level.

There is no indication that the increase in cannabis jobs is going to slow down any time soon. For example, 2017 saw a 21 percent increase in the number of jobs created in the industry while that number jumped to 44 percent in 2018. 2019 should show a higher rise in the percentage of new jobs created.

You may be wondering how the cannabis workforce increase compares to other sectors/industries. According to the Bureau of Labor Statistics, three industries are likely to have the highest increase in jobs over the coming ten years.

The demand for wind turbine technicians is expected to increase by 96 percent while the demand for solar voltaic installers is likely to increase by 105 percent. The need for home health care aides will rise by 47 percent. All these figures predict workforce increases over at least a decade. However, the data collected by Leafly and Whitney Economics shows that the marijuana industry will achieve a 110 percent increase in jobs created in just over three years!

The figures get even more astounding when they are broken down on a state-by-state basis. For example, Florida saw a 703 percent increase in the cannabis jobs created during 2018. New York ended 2018 with an extra 5,000 full-time jobs in the cannabis industry, marking an increase of 278 percent.

Five states (Oklahoma, California, Arkansas, Massachusetts and Florida) are currently in need of thousands of employees in the cannabis sector, and this demand may keep rising over the coming years as the industry matures. Net Element, Inc. (NASDAQ: NETE) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) welcome the research done by Leafly and its partners since this data proves that cannabis can bring huge economic benefits wherever it is legalized.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

A petition that is intended to put medical marijuana on the ballot in 2020 has received approval from the Nebraska Secretary of State. This clears the way for the petitioners to start gathering signatures in order to have the ballot measure included among the issues to be voted on during the 2020 elections.

Medical marijuana activists, together with two state senators (Anna Wishart and Adam Morfeld) formed a committee last year to explore ways of getting voters to decide on the matter. This was after numerous attempts to legalize medical marijuana through legislative means failed. The senators involved in this petition are both Democrats.

The petition seeks to amend the constitution of Nebraska so that patients can be given a right to use, access, possess and safely use marijuana materials and products in order to alleviate serious medical conditions that a nurse practitioner or doctor regards as something that can be alleviated by the use of medical cannabis.

By law, petitioners are required to submit their petition to the secretary of state so that the wording of that petition can be approved. The advocates duly submitted their petition last month and it was approved on Friday last week (March 1).

Senator Morfeld announced that since the petition had been approved, plans to legalize medical cannabis in the state would now shift gears to the phase of collecting signatures in support of the petition.

That task of collecting signatures isn’t a small one given that the constitution stipulates that any petition must have the support (by way of signatures) of at least 10 percent of all the registered voters in the state.

Furthermore, the petitioners are required to collect signatures from a minimum of five percent of all the voters in at least 38 counties in the state (out of a total of 98 counties).

Senator Wishart has revealed that they will try to push for a legislative solution as they gather signatures for the ballot measure petition.

However, chances are slim for a bill legalizing marijuana to become law in the state. This is because Gov. Pete Ricketts (R) is determined to use his veto powers to block any law that seeks to legalize marijuana in the state. A ballot measure therefore seems the only realistic way to get medical marijuana legalized.

Medical Cannabis Payment Solutions (OTC: REFG) and MustGrow Biologics Corp. wish the petitioners all the best as they try to get medical cannabis legalized so that the patients in the state can have an extra treatment option for their medical challenges.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

If you were asked to make a random guess about how much weed Canadians bought (and presumably consumed) since recreational marijuana was legalized in October last year, what would you say? Well, Statistics Canada released recreational cannabis sales data and the figures are surprising, to say the least.

The statistics show that in October last year, Canadians bought recreational cannabis worth $32.7 million while November sales amounted to $40.4 million. In December, Canadians bought recreational cannabis products worth $41.9 million.

These figures are considered to be highly reliable because the Canadian marijuana market is highly regulated. You should therefore not doubt that the first three months of legal recreational pot resulted in total sales of $115 million. That is shocking, given all the hype that accompanied the lead up to legalization.

However, a number of factors may explain why annual recreational cannabis sales are likely to be far less than was predicted.

First, the persistent supply shortages have made it hard for all Canadian who would like to use weed to buy the substance as often as they would like. Without weed on the shelves, where would the sales come from? Many licensed producers predict that it may take years for them to ramp up their production to a level that can meet the current demand.

Secondly, Health Canada has also played a part in dampening the performance of the recreational cannabis sector. The regulator has been very slow in processing the applications for the different entities that would like to become licensed producers/cultivators of cannabis in the country. There are claims that Health Canada takes several months or even years to make a decision on an application. This sluggish way of conducting their business has made it hard for enough producers to be active in the country, hence the supply shortages.

Another reason for the low recreational cannabis sales has to do with a shortage of packaging and processing facilities. There are reports that harvested cannabis takes unnecessarily long to reach the shelves of retail outlets because the few processers licensed in the country cannot handle the volume of weed available for processing and packaging.

Not surprisingly, the packaging and processing problem also goes back to Health Canada who have been slow in issuing processing or packaging licenses to interested players.

Finally, the provinces may also have a role to play in the dismal sales statistics. For example, Ontario has only been selling recreational cannabis through the state-run online outlets. While there are plans to open offline stores, the current sale in online stores alone has reduced the potential sales that would have been made in the densely populated cities within the province.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America Inc. (OTCQB: MCOA) look forward to a speedy resolution of all the limiting factors above so that the Canadian cannabis industry can reach its full potential.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Multifaceted financial news and publishing company CannabisNewsWire (“CNW”) this morning announced that it will serve as a media sponsor for Cannabis Conference 2019 taking place from April 1 through April 3, 2019 at the Westgate Las Vegas Resort and Casino in Las Vegas, Nevada. The premier event, produced by GIE Media Inc., offers exceptional networking opportunities, unprecedented insights from some of the brightest minds in the cannabis industry, and the latest technologies, solutions and services to advance its various sectors, including cultivation and business operations, retail management and customer engagement. “We are really excited to be part of this amazing conference as a media sponsor,” CNW Director of Syndicated Communications Christopher Johnson stated in the news release. “The cannabis space is a robust, dynamic industry that is challenging conceptions and pushing boundaries. Cannabis Conference organizers have designed the perfect platform for stakeholders to deep dive into challenges facing the industry. We are honored to be part of this must-attend conference and look forward to participating alongside other sponsors supporting this event.”

To view the full press release, visit http://cnw.fm/U3SUc

About Cannabis Conference 2019

Cannabis Conference 2019, presented by Cannabis Business Times and Cannabis Dispensary, will bring industry stakeholders together to engage the biggest opportunities and challenges facing the legal cannabis market. The three-day event will be held at Westgate Las Vegas Resort and Casino in Las Vegas, Nev., April 1-3, 2019. Cannabis Conference will expand the successes of previous events’ cultivation education and will include for the first time a dispensary track for retail businesses and employees. The conference will feature in-depth educational programming on cannabis cultivation and business operations, as well as the most informed industry perspectives on retail management and customer engagement. The Cannabis Conference exhibition hall will feature industry-leading technologies, solutions and services for the professional cannabis cultivator and retail businesses. For more information, visit www.CannabisConference.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Following the recommendations by the World Health Organization (“WHO”) that whole-plant cannabis and its resin should be reclassified, the U.S. FDA has issued a notice asking interested parties to submit their views on this matter so that the position that the U.S. takes when the matter comes up for a vote at the UN is informed by the views collected.

While this is the third time that the federal government is asking stakeholders for input on marijuana rescheduling, it is the first time that they are doing so from the time WHO released its recommendations.

The World Health Organization observed that the evidence that was presented before its expert committee didn’t show that marijuana deserved to be in the same category as the other substances in Schedule IV of the treaty setting up guidelines on how various substances should be controlled internationally.

The UN body also made it clear that CBD, one of components of cannabis, should not be subjected to any international controls.

Additionally, the World Health Organization admitted that cannabis and its derivatives had demonstrated therapeutic benefits for a number of conditions, such as pain and multiple sclerosis.

The FDA explained that interested people would have up to March 14 to submit their views for consideration. This deadline was set based on an earlier timeline for the planned meeting of the UN Commission on Narcotic Drugs. That meeting is expected to be held anywhere between March 14 and March 22 this year.

That original timeline was set because the WHO was expected to release its recommendations in December last year. However, that didn’t happen for unknown reasons.

The FDA therefore expects to extend the period within which members of the public and other stakeholders in the U.S. can submit their comments if the UN communicates that the Narcotics Committee will sit at a later time. The alternative dates for that meeting are in December this year or March next year.

The views collected by the FDA will be analyzed and the findings forwarded to the Department of Health and Human Services. HHS will then formulate a recommendation of the position that the U.S. State Department should take when the matter of reclassification comes up for a vote at the UN.

This call for public comments provides a golden chance for stakeholders to play a role in shaping how the federal government will vote on the matter at the UN. Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Green Hygienics Holdings Inc. (OTCQB: GRYN) call upon everyone with an interest in the cannabis industry to share their views with the FDA so that the U.S. can vote in a way that reflects the wishes of the people back home.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

As momentum gathers to legalize recreational cannabis in New Hampshire, a House committee has passed a bill permitting patients enrolled on the medical cannabis program to grow their own marijuana, as well as other measures intended to expand the medical marijuana program.

The Human Services and Elderly Affairs Committee of the New Hampshire Assembly voted on Tuesday last week to allow patients or their caregivers to have three mature cannabis plants, three immature plants as well as 12 seedlings of cannabis.

The bill also included a raise on the cap of medical marijuana that a patient could have from 6 to 8 ounces.

The move to allow patients to grow their own cannabis and also possess higher amounts of the substance is intended to ease the inconveniences that some patients in distant locations were facing in accessing one of the four medical marijuana dispensaries run by the state.

The contents of the bill are also intended to allow patients to customize their medical cannabis without incurring a high cost. For example, one patient (Heather Marie Brown) revealed that she spends $400 each month on medical cannabis to treat PTSD. However, with home-grows now set to be allowed, she will spend approximately $150 to grow all the cannabis she needs for her condition.

There were calls for the committee members to increase the number of qualifying conditions, but this wasn’t acted on because the lawmakers felt that it was premature for them to make a decision on that matter yet a special committee of medical experts set up to advise the State on the qualifying conditions is scheduled to meet this month (March) to discuss that same matter.

One of the qualifying conditions that was being considered for addition to the list is opioid addiction. However, many legislators were hesitant to approve its inclusion because there was insufficient evidence that cannabis could wean people off prescription opioids. Other lawmakers didn’t think it would be good to recommend the use of one potentially addictive substance as a replacement for another addictive substance/drug.

Meanwhile, the entire House is scheduled to vote on a proposal to legalize recreational marijuana across the state. Previous attempts to get recreational cannabis legalized in the state met with dismal failure, but hopes of success are high this time round since Democrats now have control of both the Senate and the Assembly.

For the sake of the patients and the general population in New Hampshire, Global Payout Inc. (OTC: GOHE) and Golden Developing Solutions Inc. (OTC: DVLP) wish for a speedy conclusion to the different bills before the legislators.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The members of the subcommittee on Medical Affairs in the South Carolina Senate have decided to stall moving a medical cannabis bill forward to the full committee until all the concerns of the different stakeholders have been taken into account. This decision was made on Wednesday (February 27).

One of the proposed changes that may be made to the bill is to include language that makes it clear that smoking medical marijuana will be outlawed. Those interested in this wording say that nothing that may create an impression that marijuana is being legalized for anything other than medical use should be permitted in the bill.

Another issue that needs further consideration is the matter of the qualifying conditions which will be listed in the bill. The legislators want more time to be taken to study the different conditions which can be alleviated by the use of cannabis. Under the current bill, terminal or debilitating conditions, such as chronic diseases and cancer are currently listed as qualifying conditions. Could other deserving conditions have been left out? The legislators want to hear from stakeholders on this before moving forward.

The members of the subcommittee also want to hear more about the fiscal implications of the proposed six percent sales tax that will be imposed on the medical cannabis sold. Will that tax make medical cannabis too expensive for some patients to afford? Are there other ways to collect revenue from the industry without imposing a sales tax? Stakeholders need to inform the members on all these financial implications before the bill is sent to the whole committee.

In its present form, the bill will allow patients enrolled on the medical cannabis program to buy up to two ounces of cannabis (or its equivalent) once a fortnight as long as a doctor has prescribed it.

Representatives of the law enforcement agencies in the state, such as the Association of South Caroline Sheriffs, have said that they would like to review the bill in order to understand the details it contains and the implications of those details. The devil is always in the details, they say.

Such sentiments give further credence to the decision of the subcommittee to wait and hash out all the concerns of the stakeholders so that the bill forwarded to the whole committee reflects the input collected from everyone concerned.

This proactive way of drafting a legalization bill is good for the cannabis industry, including Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) and Earth Science Tech, Inc. (OTCQB: ETST).

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Baby boomers (those born between 1946 and 1964) are rediscovering cannabis and the industry is taking note of this demographic. However, like everything else, time has exerted its influence on marijuana and the baby boomers would be well advised to keep the following important tips in mind when consuming cannabis.

Start Small

The cannabis of today isn’t the same as what was available decades ago. Plant breeding has yielded cannabis strains that may have more than triple the THC content which was found in the marijuana of the 1970s. It is therefore advisable for you to be cautious when you are just starting out on your “boomerang” journey of reigniting your love for a joint.

Select the Dispensary Carefully

Baby boomers would also be well advised to take their time as they select the dispensary from which to buy marijuana. It is better to select an establishment which has a knowledgeable “budtender.” Such a person will help you to navigate your way through the huge array of cannabis products that are now available in the different dispensaries or retail outlets.

Know the Outcomes You Desire

A knowledgeable budtender can only go so far in helping you to get the right product. You need to make it possible for this person to help you by deciding the effects that you would like to experience when you consume the cannabis you buy. The plant breeding processes mentioned earlier have resulted in the development of different cannabis strains for different purposes.

For example, some strains will calm down your mind as you get ready to sleep while others will reinvigorate your mind and body while you get set for some physical or mental exertion. It is therefore crucial for you to know what experience you want so that the budtender can point you in the right direction.

Learn the Lingo

The cannabis industry has come with its own unique language that one must learn in order to avoid making mistakes. For example, you need to know how “cannabis flower” differs from cannabis “edibles” or “concentrates.” The budtender may help to explain some of the new terminologies you encounter as you explore the new world of marijuana, but it doesn’t hurt to invest some time online learning the language of the industry.

Think About Your Current Medication

It is also helpful to consider how any medication you are currently taking may interact with cannabis. For example, cannabis may increase the uptake of some of the medication you are on, and this may increase the side effects of that medication. To be on the safe side, take the precaution of talking to your doctor first before you consume cannabis.

The cannabis industry, including companies like FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) and Generation Alpha, Inc. (OTCQB: GNAL), hopes that each baby boomer attains the results for which they try cannabis.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]